Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931948	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	12.6	7.5	4.4	8.4	6.4	16.9	9.7	11.4	6.2	9.1	5.7	9.1	6.5	8.8	6.6	9.2	7.0	7.4	6.6	4.7	6.2	9.8	10.9	7.2	9.1	3.3	5.6	16.2	10.0	13.1	6.4	8.8	3.7	7.6	6.9	8.1	6.8	7.9	11.0	8.0	6.6	7.9	3.8	9.2	8.5	32.5	7.0	12.2	13.7	15.7	9.0	10.3	7.1	4.8	37.9	25.9	24.6	20.7	24.3	23.6	32.4	24.2	19.3	29.1	24.2	26.5	19.4	37.6	24.6	21.6	16.4	34.1	40.3	20.9	49.7	21.0	9.0	26.4	29.0	24.2	17.4	40.8	17.8	22.8	18.5	37.9	38.4	13.9	21.9	18.5	61.2	24.4	27.8	12.5	31.5	19.2	42.4	34.1	18.4	30.4	32.6	32.1	18.3	28.0	22.1	28.6	34.9	19.5	20.3	18.3	22.1	29.2	20.1	26.3	22.5	33.2	55.7	25.8	38.9	45.4	19.5	27.0	26.2	0.3	0.2	0.7	0.5	0.1	0.5	0.7	0.7	0.6	0.2	0.4	0.8	0.6	3.0	0.4	0.4	0.4	0.8	0.3	4.4	6.4	11.4	6.2	4.7	6.2	3.3	5.6	3.7	3.8	7.0	4.8	53.7	35.3	35.0	37.2	32.9	30.0	22.4	10.3	40.5	19.8	15.9	21.7	21.1	7.2	20.7	5.5	8.4	14.1	27.4	15.7	3.9	12.5	63.7	29.1	30.9	25.9	21.6	20.8	62.2	12.4	10.8	30.5	21.9	28.8	12.0	20.3	17.2	14.3	9.3	18.5	55.7	12.9	10.2	13.2	13.8	23.7	36.1	57.4	3.6	29.0	17.7	8.9	26.8	46.8	51.3	16.2	13.0	39.1	35.8	27.7	11.9	8.8	20.4	17.1	32.9	70.9	26.1	116.7	37.6	27.3	30.7	13.5	31.3	21.4	12.4	26.2
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.6"	"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	3.5	3.1	8.1	3.3	9.9	3.7	4.8	13.5	17.2	3.5	10.9	4.6	3.6	4.3	7.6	4.3	7.9	3.5	4.9	6.4	11.0	5.3	3.1	4.1	4.2	8.8	10.7	3.6	3.4	9.2	7.7	3.1	9.5	3.9	4.5	14.1	5.1	3.9	4.8	3.9	3.6	3.9	10.7	4.0	4.5	16.6	8.7	7.6	6.9	3.5	3.6	3.4	3.2	13.4	2.3	1.6	6.6	11.5	6.1	3.7	4.8	3.5	4.3	3.6	4.9	2.6	4.6	4.9	1.7	3.4	7.9	3.7	1.9	3.9	7.6	10.2	4.0	3.8	3.8	2.6	4.8	4.4	2.3	3.1	7.3	6.6	8.6	8.8	4.2	7.2	3.6	4.0	2.7	4.7	4.1	3.2	1.5	5.1	2.5	5.5	3.7	4.7	5.0	4.3	7.8	6.4	4.2	3.9	5.9	3.7	5.1	5.8	5.2	3.1	2.2	5.1	2.3	2.0	1.8	2.8	6.8	5.9	2.0	17.1	2.8	7.1	5.1	1.5	4.4	13.1	4.9	6.2	2.1	10.8	6.2	5.4	5.6	5.6	4.8	3.1	3.9	1.6	8.1	9.9	13.5	17.2	6.4	11.0	8.8	10.7	9.5	10.7	8.7	13.4	13.3	28.9	17.2	21.2	13.6	2.7	7.7	14.7	3.4	18.3	10.4	6.7	18.9	5.7	19.9	9.2	14.6	3.4	8.6	13.1	0.0	9.1	70.9	76.3	5.4	10.0	19.8	4.2	34.8	4.5	1.5	6.0	12.2	7.3	22.1	10.6	8.9	2.1	3.6	20.2	37.0	15.5	14.2	5.3	3.9	41.7	7.5	5.6	5.4	25.3	5.0	12.6	18.6	22.6	46.9	7.4	8.9	6.4	5.5	5.6	22.9	6.8	152.0	50.7	26.3	9.1	6.9	174.3	34.1	4.0	2.6	5.6	10.3	4.7	11.4	7.9
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61679139-61863528	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0"	"Group enriched"	"Detected in many"	12	"Early spermatids: 186.2;Late spermatids: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	0.3	0.3	0.8	1.7	0.6	7.2	0.9	1.3	0.9	0.4	0.0	1.7	2.0	0.8	0.4	1.5	0.3	0.6	0.1	0.5	0.2	0.3	1.6	0.4	2.8	0.3	0.0	1.1	0.3	0.1	0.0	0.8	0.4	0.4	1.9	0.5	0.4	0.2	0.1	2.0	1.9	0.9	0.0	0.7	0.9	7.0	0.2	5.9	0.3	0.1	3.3	0.7	0.6	0.8	26.6	9.4	25.0	14.1	0.9	2.1	5.5	23.6	13.3	24.6	31.8	9.5	8.0	14.9	5.2	4.9	7.7	9.2	12.8	4.5	33.3	3.8	15.8	15.5	14.4	10.5	0.2	20.3	8.8	0.6	0.4	20.2	5.1	3.4	5.0	14.8	11.6	10.5	14.4	88.9	32.5	6.7	5.3	5.9	7.3	19.7	50.1	7.1	3.0	12.8	10.0	24.2	9.4	3.0	3.3	9.1	8.3	7.3	4.5	36.9	26.5	13.5	26.6	6.3	13.3	16.6	7.3	9.3	8.8	1.0	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.1	0.1	0.6	0.4	0.2	0.3	0.1	0.1	0.1	1.0	0.1	0.8	0.6	1.3	0.9	0.5	0.2	0.3	0.0	0.4	0.0	0.2	0.8	0.2	0.0	0.5	1.0	1.6	2.3	1.3	0.8	0.6	0.3	1.1	1.8	0.6	0.0	4.0	0.0	0.0	2.0	2.0	1.8	0.0	0.3	186.2	0.7	1.7	0.8	0.0	7.4	4.6	0.2	3.0	2.0	2.0	1.6	0.0	15.5	0.4	3.4	1.7	0.0	3.3	1.8	0.0	0.8	1.1	194.1	1.2	1.0	3.6	2.8	0.6	0.2	1.0	1.5	1.0	0.8	0.1	1.2	4.8	0.4	1.4	0.2	0.8	0.2	0.0	2.5	1.8	12.1	6.0	2.9	0.4	0.3	2.3	2.1	4.7	0.7
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"glioma: 175.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 2594.8;LHCN-M2: 2819.4;RH-30: 8902.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	69.7	87.8	35.0	52.8	37.9	72.0	76.6	37.7	36.9	84.3	35.9	62.6	40.2	97.4	64.2	57.2	69.4	57.1	58.9	33.6	37.1	58.5	51.5	58.0	66.8	37.1	36.9	97.3	70.9	63.5	67.7	52.4	36.8	52.7	63.3	14.5	54.4	54.1	48.2	58.9	47.2	80.4	37.3	51.5	54.8	24.1	37.3	67.6	66.0	52.7	70.6	71.6	60.7	37.6	207.1	235.7	295.7	268.0	253.7	220.7	210.4	116.1	347.9	468.5	385.7	338.2	189.1	297.4	200.2	173.6	293.2	158.0	396.3	2594.8	354.9	150.9	209.0	275.4	149.5	237.9	297.0	309.7	182.5	221.5	180.9	294.2	326.7	326.4	304.8	280.0	301.3	242.7	2819.4	304.9	296.7	256.5	347.0	208.0	249.8	267.3	8902.5	272.1	147.2	320.6	271.2	251.7	205.3	150.2	310.0	195.1	202.8	380.7	146.1	233.6	217.0	265.8	233.1	122.2	206.1	450.8	214.1	291.3	286.9	9.5	46.5	10.3	79.6	65.6	81.8	93.5	70.0	72.5	66.7	90.0	93.0	84.4	4.4	56.6	41.9	84.9	57.0	73.6	35.0	37.9	37.7	36.9	33.6	37.1	37.1	36.9	36.8	37.3	37.3	37.6	47.1	22.4	30.8	7.8	40.0	89.7	78.6	83.4	74.0	15.9	67.2	82.2	0.7	51.5	35.3	47.8	10.4	82.9	26.1	15.9	70.5	93.1	13.5	14.9	77.7	50.8	45.6	98.0	5.2	62.5	134.5	79.4	28.5	22.6	69.1	60.2	39.7	35.8	132.9	18.5	6.7	42.2	40.7	25.1	44.1	8.0	64.0	31.2	53.4	6.5	41.9	51.4	29.9	5.5	8.0	48.3	18.9	63.2	57.8	113.9	14.0	80.9	7.4	17.9	32.9	62.1	61.9	32.1	48.3	74.5	86.1	46.8	32.3	78.8	78.7	49.4
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"	95.0	307.2	126.3	53.1	171.3	80.1	100.1	170.2	165.7	96.8	141.7	81.5	94.5	79.9	89.6	46.2	94.1	97.1	71.8	125.5	144.8	261.4	732.2	135.0	56.4	201.5	168.5	104.4	129.3	159.4	84.7	113.8	192.1	83.2	88.6	38.1	61.5	82.7	37.5	46.9	102.8	99.2	158.7	65.1	128.0	49.8	157.2	67.5	161.4	57.3	69.9	91.0	70.7	223.7	154.3	175.8	138.1	277.9	395.1	237.1	100.8	153.1	217.9	278.1	189.1	188.4	248.5	137.7	244.3	242.4	174.6	165.5	195.5	160.7	247.6	194.0	157.7	193.4	107.5	219.3	277.6	216.4	218.5	214.0	197.9	254.3	315.6	341.4	174.3	189.8	210.4	281.0	363.4	255.6	134.2	135.7	200.9	499.4	299.6	160.0	95.4	208.4	311.5	127.2	121.7	185.8	169.6	278.7	183.8	172.1	335.6	296.5	145.4	196.4	93.6	180.1	267.9	189.5	229.0	841.7	222.4	91.0	200.7	212.1	80.2	136.0	76.9	43.7	93.6	34.6	70.3	78.8	69.5	31.9	60.6	60.1	86.5	63.4	32.8	70.1	86.7	88.5	126.3	171.3	170.2	165.7	125.5	144.8	201.5	168.5	192.1	158.7	157.2	223.7	46.3	67.3	67.9	8.8	23.1	24.1	38.2	37.0	18.2	7.5	52.8	27.6	2.8	120.1	23.2	53.3	4.2	77.8	40.2	60.7	13.7	104.6	7.5	24.9	39.9	47.9	24.6	24.8	5.5	92.8	42.4	44.2	16.3	29.7	36.8	33.0	38.9	200.5	55.9	3.3	5.9	29.3	30.5	45.2	35.2	7.9	56.2	54.5	37.4	5.6	39.4	26.5	26.8	7.5	51.3	103.7	32.4	40.3	29.2	52.4	98.8	81.7	21.2	9.9	39.5	37.2	33.8	13.8	6.8	13.9	15.6	54.2	34.3	39.0	29.1	34.2
CLK1		ENSG00000013441	"CDC like kinase 1"	P49759	2	200853009-200864744	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033141, HPA062405"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Nuclear membrane"		"CAB033141: AB_1121713, HPA062405: AB_2684753"	"unprognostic (9.79e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.19e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (9.66e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (2.28e-4)"	89.6	82.7	132.9	25.4	137.1	178.0	72.2	140.9	201.6	118.5	136.2	78.3	20.8	65.8	51.1	58.5	85.5	56.5	83.9	133.9	137.7	83.3	84.4	90.3	55.9	138.1	133.4	140.3	63.6	29.0	82.3	64.8	138.6	109.7	24.2	133.8	68.9	49.6	80.4	62.5	51.6	30.9	135.2	113.0	53.2	28.1	134.1	76.0	92.5	71.4	42.0	77.8	112.8	176.0	17.9	13.5	22.6	6.5	24.4	26.1	17.1	19.2	26.8	19.3	25.5	24.6	11.8	5.5	13.1	11.4	11.1	19.7	27.9	8.8	38.2	27.3	24.0	18.1	35.9	30.7	14.7	19.5	31.1	12.3	39.9	23.4	41.8	20.6	11.4	9.5	23.3	77.1	27.0	12.3	23.0	58.4	13.9	11.4	29.8	24.8	25.7	31.8	13.0	11.2	22.0	17.8	16.4	6.1	32.7	12.9	5.3	13.2	19.5	21.4	14.8	21.5	22.0	46.8	20.9	13.7	14.2	15.4	14.9	40.0	7.2	18.6	14.5	5.0	17.3	17.4	15.7	15.8	4.8	11.7	15.6	12.9	16.9	9.5	6.0	11.1	17.2	10.4	132.9	137.1	140.9	201.6	133.9	137.7	138.1	133.4	138.6	135.2	134.1	176.0	122.1	44.8	85.4	112.0	164.2	168.8	263.0	73.6	114.4	59.0	112.9	97.0	96.6	41.5	87.1	27.6	100.1	46.7	213.5	110.9	19.6	31.4	2.3	111.2	108.8	113.6	134.3	87.5	51.7	26.9	56.6	142.5	81.1	173.6	136.9	77.9	82.1	43.3	58.5	52.2	53.6	124.2	50.8	100.5	285.8	9.4	92.9	192.3	154.7	62.8	56.2	54.6	76.2	58.3	169.0	32.0	117.7	75.6	169.0	133.3	88.2	14.9	70.1	99.6	111.7	97.8	128.4	33.1	27.7	117.0	151.7	90.3	261.2	43.0	88.6	184.2
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065876, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA065876: , HPA072634: AB_2686541"	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	61.0	47.9	15.5	50.5	15.2	70.9	58.5	14.5	17.5	68.7	17.0	65.4	32.5	74.1	58.5	58.7	62.4	48.3	38.4	15.2	15.8	44.1	38.7	59.6	52.3	16.9	14.6	64.7	48.4	38.6	52.1	69.8	15.4	52.3	47.4	17.7	51.6	41.9	43.7	63.4	62.9	70.3	14.5	78.3	51.0	25.5	14.9	82.8	60.2	33.6	81.8	64.4	59.8	19.6	264.1	202.5	112.0	47.3	14.3	18.6	85.4	123.9	219.8	295.0	192.1	590.5	111.2	181.6	115.8	185.3	251.6	98.1	88.1	233.7	182.8	34.7	65.7	459.1	149.9	440.5	131.9	151.5	61.9	121.6	235.8	118.1	139.0	178.9	188.1	183.9	61.4	90.3	144.0	142.9	226.0	201.9	27.8	264.2	187.6	159.1	334.0	125.4	119.9	183.9	78.9	87.9	277.2	129.6	188.1	31.1	134.3	148.8	123.6	306.6	56.4	101.3	131.6	61.5	66.9	126.9	222.7	81.8	69.6	53.6	102.9	180.5	119.3	100.5	164.8	120.8	115.2	112.5	143.7	113.8	111.3	113.6	140.4	206.7	98.8	78.0	153.7	164.5	15.5	15.2	14.5	17.5	15.2	15.8	16.9	14.6	15.4	14.5	14.9	19.6	47.0	19.2	37.3	33.6	55.2	55.1	71.8	82.3	44.9	34.6	40.2	46.0	15.7	32.9	56.5	25.8	20.9	125.1	73.4	26.8	25.4	72.7	39.6	23.3	44.1	53.2	33.6	42.5	37.2	37.8	76.7	56.2	25.0	28.3	48.2	59.9	34.6	23.3	62.4	21.9	33.7	30.8	81.4	43.0	79.6	9.6	54.7	45.5	48.0	30.0	85.0	24.8	62.8	32.6	39.4	44.2	34.0	61.7	60.2	78.6	38.2	34.8	33.9	18.1	46.0	47.0	55.0	13.1	22.9	41.4	49.0	106.3	77.0	65.9	41.2	71.7
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355149	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.1	29.8	18.3	18.1	19.5	27.6	24.5	20.0	20.4	21.6	19.5	23.3	21.4	24.0	23.4	23.2	20.8	17.5	26.8	19.0	18.1	23.9	28.0	21.1	16.4	20.0	18.8	22.6	26.9	32.9	23.7	20.3	19.1	23.4	14.7	16.6	28.4	17.7	37.5	28.5	20.7	19.0	18.4	24.8	23.9	21.4	18.9	17.3	23.5	23.5	16.0	21.6	20.6	20.0	37.4	38.3	23.4	39.3	30.5	31.1	29.6	36.6	63.8	49.5	45.9	44.7	64.3	27.2	28.8	45.1	31.3	61.4	22.2	33.0	26.9	29.9	29.4	14.7	23.0	29.6	68.5	30.1	54.2	39.6	67.6	44.1	55.8	45.0	35.1	25.6	23.2	40.2	43.3	36.7	26.0	26.3	10.8	29.1	11.1	23.4	17.8	18.9	37.7	21.7	16.1	23.0	20.0	74.0	36.8	12.9	28.2	34.2	39.1	24.6	33.4	28.0	46.7	33.8	27.3	16.0	40.6	32.6	17.1	18.7	29.2	18.7	12.8	31.5	11.4	11.5	12.5	9.6	24.6	11.1	10.3	10.2	36.6	13.9	28.9	16.4	13.8	17.5	18.3	19.5	20.0	20.4	19.0	18.1	20.0	18.8	19.1	18.4	18.9	20.0	30.3	28.9	29.3	10.1	30.1	13.4	30.6	38.6	25.6	33.3	36.1	29.6	23.3	50.1	44.3	23.9	22.9	41.1	37.7	38.1	11.7	34.2	122.2	25.1	26.1	25.3	29.4	31.2	12.7	64.3	41.1	28.6	23.4	29.3	40.0	26.4	21.0	29.6	38.1	30.3	13.0	28.8	12.2	36.0	16.0	235.7	36.4	37.6	10.6	7.5	39.6	33.6	35.0	12.1	15.2	34.9	38.1	35.0	34.2	27.4	62.2	34.4	26.8	35.6	52.6	27.4	34.4	32.4	10.9	28.1	15.5	68.0	22.8	37.0	25.9	35.2
DNAJB2	"CMT2T, HSJ1, HSPF3"	ENSG00000135924	"DnaJ heat shock protein family (Hsp40) member B2"	P25686	2	219279342-219286898	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Chaperone	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 366.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036268	Approved		Enhanced	"Nuclear membrane"		NA	NA		9900	"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA036268: AB_10670793"	"unprognostic (2.02e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.62e-3)"	41.9	106.9	264.5	17.7	290.6	26.6	45.7	276.0	323.5	63.8	232.0	48.9	23.2	46.2	45.2	54.1	48.2	26.6	85.4	266.6	270.7	81.0	72.1	45.8	26.0	281.8	281.8	65.0	84.8	54.3	112.1	27.1	279.7	73.9	15.8	63.9	62.3	35.5	135.6	108.1	36.0	15.8	269.7	46.7	54.8	86.0	280.5	28.4	71.0	56.5	20.5	52.8	59.0	366.0	34.9	14.2	21.9	20.7	45.6	22.1	29.3	32.8	27.2	29.0	24.2	66.2	21.3	21.4	39.7	31.6	66.3	49.1	27.9	36.3	16.3	45.3	12.2	41.7	28.0	32.0	30.8	7.1	36.5	21.3	103.3	31.8	38.4	51.3	12.9	23.5	7.4	23.7	21.4	18.0	13.0	8.4	12.9	30.2	26.4	13.4	17.9	13.5	31.7	24.5	20.6	26.0	38.0	38.4	64.9	57.5	28.6	14.9	17.5	41.6	82.3	12.0	28.6	26.2	8.4	35.0	42.8	6.5	31.1	0.0	0.4	2.1	0.7	0.4	0.6	0.5	0.7	0.6	0.2	1.7	1.0	0.9	0.4	1.3	1.2	0.6	1.0	0.4	264.5	290.6	276.0	323.5	266.6	270.7	281.8	281.8	279.7	269.7	280.5	366.0	24.6	19.2	31.4	35.6	30.9	28.6	40.9	17.1	9.1	97.9	61.9	33.9	77.4	25.8	18.0	38.6	56.3	36.1	24.0	41.5	78.2	60.0	43.8	43.5	16.2	22.3	53.7	69.9	17.9	33.5	34.7	27.5	22.4	27.9	24.8	22.1	20.7	20.5	28.2	80.8	26.5	47.5	10.2	19.7	28.2	70.9	36.4	28.0	32.0	11.2	21.6	84.8	15.5	16.6	144.2	68.9	23.6	39.1	28.5	39.8	31.7	56.5	39.0	87.3	19.7	27.3	28.3	56.5	20.6	18.9	50.4	69.0	30.2	23.1	25.5	25.8
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 67.7;CAPAN-2: 110.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear membrane"		"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	10.0	5.0	5.6	12.3	6.3	5.1	10.3	3.3	10.1	17.4	13.8	15.8	10.2	9.3	1.1	54.0	10.5	9.3	6.8	4.3	5.9	5.4	8.7	10.3	10.9	11.1	8.1	8.1	10.5	8.4	6.7	5.3	8.1	13.7	8.1	4.4	30.4	3.9	12.5	31.0	13.3	4.3	3.8	13.3	14.2	28.1	13.5	9.0	7.9	2.7	10.1	12.1	27.2	12.8	31.8	67.7	9.9	14.7	5.5	5.4	21.2	6.8	5.7	7.2	9.9	19.1	110.9	9.8	4.7	6.8	38.1	23.2	5.3	32.1	4.5	22.1	11.3	5.6	14.4	16.9	7.4	8.2	13.7	9.6	19.1	18.7	10.0	5.6	5.5	17.2	17.3	14.3	8.8	15.3	12.6	28.6	14.4	23.8	10.2	13.8	9.1	17.7	3.4	24.4	3.9	8.2	10.9	18.4	9.3	8.6	18.5	21.6	5.8	40.5	19.0	13.8	27.1	10.7	13.7	11.2	8.8	8.8	21.3	17.7	11.6	17.2	8.6	13.3	6.2	6.6	7.1	8.5	10.1	7.3	7.1	7.9	22.8	4.2	18.8	17.8	11.0	8.4	5.6	6.3	3.3	10.1	4.3	5.9	11.1	8.1	8.1	3.8	13.5	12.8	7.3	6.4	5.0	5.2	13.1	33.9	19.5	87.2	23.3	2.6	7.1	4.8	2.3	4.3	59.2	7.3	8.4	18.5	12.0	39.1	3.9	19.4	33.0	8.1	3.1	5.9	9.1	3.8	5.7	10.8	13.5	6.5	61.2	10.7	3.8	3.2	7.1	4.3	21.6	3.3	5.2	25.6	22.4	11.0	7.7	10.4	5.6	14.5	7.2	19.7	10.0	5.7	8.2	18.1	10.0	23.1	37.9	4.9	13.9	20.0	21.0	3.2	62.8	9.2	6.6	3.0	7.3	11.0	11.0	27.0	35.4	37.6	9.7	1.9	26.1	62.5
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	17.0	6.0	7.6	18.6	11.6	129.5	5.5	7.5	55.0	8.1	9.2	4.5	1.6	7.0	7.7	6.8	7.6	12.5	19.5	13.4	6.2	12.7	7.5	18.2	47.1	8.0	6.3	7.8	2.3	1.7	35.1	1.3	6.7	17.6	2.0	0.4	3.9	61.5	2.8	26.0	11.8	3.4	6.7	42.0	7.4	3.6	6.9	47.3	6.7	3.7	24.6	39.5	9.0	9.3	3.2	0.0	0.2	0.2	0.4	0.5	4.4	3.7	0.0	5.3	5.1	8.9	0.6	30.4	10.6	4.1	0.0	2.2	7.5	0.0	1.0	0.5	0.0	0.7	29.7	0.0	1.9	12.8	2.6	0.9	2.0	0.9	0.0	0.1	0.0	27.6	0.0	33.8	0.2	5.2	25.5	29.1	6.5	0.8	10.6	0.0	0.4	24.3	0.2	34.2	29.6	1.5	1.4	0.3	5.6	0.0	2.0	14.4	0.1	0.0	7.9	0.0	1.7	2.3	3.9	43.2	0.0	13.9	0.3	2.3	4.3	1.0	199.3	10.5	95.4	17.5	46.7	176.2	10.7	13.9	32.0	99.3	6.1	148.1	9.1	3.0	16.1	40.5	7.6	11.6	7.5	55.0	13.4	6.2	8.0	6.3	6.7	6.7	6.9	9.3	50.8	0.0	7.7	0.7	303.7	96.7	155.0	31.3	70.6	27.8	65.8	72.0	37.8	2.8	12.0	9.2	22.9	0.9	919.7	20.4	1.9	0.9	0.9	115.6	62.7	28.7	87.8	50.5	5.2	1.4	1.7	22.8	86.6	321.1	104.3	7.4	12.8	3.9	80.2	0.0	1.4	37.5	8.2	40.4	924.0	1.4	1.8	353.9	144.1	1.9	3.4	1.5	90.6	1.0	0.5	1.0	2.5	1.9	268.5	70.4	1.6	1.4	2.7	3.6	0.0	14.7	26.6	0.6	4.8	50.4	109.7	1.6	764.7	3.0	51.6	41.1
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379273-154381523	"Disease related genes, Human disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		240000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	"Endoplasmic reticulum"	"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	32.8	32.5	27.4	15.4	27.4	26.5	33.2	27.8	31.8	46.6	26.6	45.7	14.7	58.2	16.0	35.0	56.2	11.2	46.2	26.0	30.1	48.7	30.6	33.3	13.8	28.5	28.6	63.9	50.5	21.3	42.6	15.5	28.2	36.5	11.1	12.9	33.5	21.8	80.3	36.3	27.2	19.9	29.2	26.9	38.5	17.3	29.7	13.0	40.6	29.7	15.4	51.2	36.1	31.4	121.3	42.4	29.0	32.7	26.3	50.6	54.7	58.1	58.2	68.5	72.4	37.9	22.6	99.6	92.2	56.2	143.5	65.5	55.8	67.4	29.5	60.6	116.8	43.7	58.4	22.5	67.9	42.9	46.8	44.1	53.2	60.4	75.0	46.5	48.3	37.5	37.0	39.0	47.9	49.2	74.4	78.1	51.3	66.3	128.9	62.1	45.9	92.4	38.4	21.9	37.9	47.8	29.8	47.6	74.2	27.8	33.6	31.2	43.5	35.7	69.6	80.2	84.2	131.4	100.6	179.3	42.3	70.9	38.1	35.5	29.5	46.4	45.2	37.3	41.8	37.8	43.1	43.6	24.8	37.0	37.7	37.7	31.0	28.7	28.1	54.9	43.3	30.6	27.4	27.4	27.8	31.8	26.0	30.1	28.5	28.6	28.2	29.2	29.7	31.4	30.3	32.1	39.5	8.1	93.1	71.8	74.8	60.9	84.2	35.1	53.4	60.1	22.3	35.8	40.4	27.6	12.5	60.7	87.4	16.6	70.5	43.5	16.3	46.5	51.8	36.2	23.9	46.7	9.6	55.0	66.4	52.9	53.5	64.4	55.1	40.9	27.1	38.8	52.2	30.3	8.8	37.0	28.5	25.2	93.0	15.4	40.7	69.4	67.6	10.3	50.2	46.9	34.0	5.5	10.8	47.7	31.3	44.8	125.8	86.4	30.9	49.5	27.9	32.6	26.3	49.5	60.1	25.4	36.2	99.3	77.0	125.1	92.7	42.3	30.4	68.3
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;retina: 71.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 138.0;Cone photoreceptor cells: 141.8;Excitatory neurons: 103.4;Horizontal cells: 85.8;Inhibitory neurons: 101.3;Muller glia cells: 191.3;Rod photoreceptor cells: 179.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.9;Hep G2: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.1	2.8	13.2	0.7	14.7	1.1	0.5	4.4	12.9	1.0	0.0	1.3	0.3	2.4	18.0	0.3	2.6	2.1	1.3	9.4	27.2	4.7	2.2	0.3	1.5	14.1	10.6	2.1	1.3	5.1	2.1	0.7	9.6	4.5	2.0	71.4	1.4	4.6	0.1	0.2	0.3	0.3	17.0	1.7	1.4	12.4	17.0	5.1	7.1	0.1	1.6	3.1	0.2	17.1	8.0	7.2	4.8	6.7	0.0	0.0	31.9	1.3	2.5	5.1	5.1	3.0	5.2	0.0	3.4	0.1	13.9	5.4	10.2	15.3	5.5	5.7	11.9	2.2	1.3	23.4	0.2	0.0	0.1	0.1	16.2	1.3	7.2	0.8	0.0	7.3	0.0	0.1	3.0	2.2	7.4	0.1	12.8	1.8	4.1	10.9	3.2	0.5	4.8	12.8	2.8	3.8	12.9	5.5	1.0	21.5	5.6	1.4	0.0	0.3	4.8	0.0	5.5	17.7	18.5	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.0	1.4	0.2	0.6	0.9	0.0	0.4	1.2	1.3	0.0	0.3	0.0	0.2	0.3	0.6	13.2	14.7	4.4	12.9	9.4	27.2	14.1	10.6	9.6	17.0	17.0	17.1	0.3	0.0	0.0	32.0	5.7	0.3	6.5	2.8	1.2	138.0	1.2	1.5	1.6	1.5	3.5	49.7	141.8	5.4	14.2	1.6	3.9	1.9	15.5	8.5	1.9	2.6	3.5	1.3	103.4	0.0	0.5	1.5	6.6	10.9	1.3	24.7	0.0	4.1	0.5	85.8	101.3	1.3	2.0	1.9	0.0	29.0	5.0	0.7	1.8	14.0	0.9	191.3	11.3	67.3	58.2	2.9	0.5	4.1	4.8	8.1	2.2	2.8	2.8	179.7	0.0	0.3	1.5	25.2	13.4	1.4	0.1	0.3	7.8	5.7	1.4	4.4
FZR1	"CDC20C, CDH1, FZR, FZR2, HCDH, HCDH1, KIAA1242"	ENSG00000105325	"Fizzy and cell division cycle 20 related 1"	Q9UM11	19	3506311-3538334	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 104.2;Late spermatids: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043536	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA043536: AB_10968058"	"unprognostic (2.78e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.04e-1)"	14.8	25.2	17.0	9.3	14.0	33.5	16.4	19.1	17.2	21.3	5.2	17.2	21.9	19.3	4.0	23.5	18.2	9.4	13.0	16.7	17.1	18.1	23.5	15.6	11.4	19.2	17.3	22.9	17.3	10.9	34.1	8.9	19.3	19.1	3.7	5.6	19.7	10.5	18.5	26.2	18.4	6.3	12.0	18.8	15.6	52.7	15.8	13.9	24.0	7.5	7.0	16.2	20.9	13.5	44.0	25.7	24.3	22.4	7.5	10.4	18.9	26.7	17.8	31.0	24.2	26.2	21.1	24.3	13.5	19.7	15.0	25.2	13.7	23.4	6.2	32.9	23.5	11.6	19.5	26.2	13.4	20.9	23.8	9.8	13.5	18.8	11.2	11.7	18.4	23.0	21.0	41.1	16.1	22.8	37.5	15.2	20.5	13.6	20.1	28.0	20.6	23.6	15.6	21.6	22.3	25.0	24.1	17.5	13.1	5.5	18.2	19.1	24.9	17.6	21.3	42.9	47.4	42.9	10.8	18.5	24.4	41.5	22.3	1.1	0.7	2.0	1.0	0.7	0.6	1.0	1.0	0.7	0.6	0.8	0.6	0.8	1.3	1.2	0.5	0.5	0.9	0.6	17.0	14.0	19.1	17.2	16.7	17.1	19.2	17.3	19.3	12.0	15.8	13.5	8.1	0.0	5.0	6.5	15.4	17.8	35.8	10.6	6.2	20.7	14.5	11.2	3.4	17.2	8.6	12.9	10.4	21.9	11.0	25.8	5.9	16.5	104.2	14.1	8.2	11.0	21.6	26.5	6.3	14.9	14.2	10.1	26.5	14.3	3.8	20.4	10.0	17.9	16.4	30.3	9.1	18.1	18.3	7.9	11.4	208.2	12.8	11.9	12.4	3.7	18.1	8.5	9.2	6.6	10.4	28.1	17.0	9.4	13.7	20.6	17.4	13.5	10.8	15.6	6.6	7.3	12.9	58.4	15.8	11.9	22.6	45.4	11.9	15.6	16.1	28.3
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GRK5	GPRK5	ENSG00000198873	"G protein-coupled receptor kinase 5"	P34947	10	119207571-119459745	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Microglial cells: 56.2;Sertoli cells: 59.2;Smooth muscle cells: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.1;HUVEC TERT2: 24.9;OE19: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025579, HPA046838"	Approved		Supported	"Nuclear membrane,Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear membrane, Nuclear speckles"	"Plasma membrane"	"CAB025579: , HPA046838: AB_2679833"	"unprognostic (1.09e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (2.38e-7)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	38.4	18.0	4.2	5.9	5.0	2.7	24.6	5.0	4.6	18.8	3.5	26.3	10.0	21.1	3.5	12.6	19.6	5.7	48.8	4.0	5.1	14.2	12.9	65.6	7.8	3.9	3.6	35.0	4.7	21.3	13.3	8.3	3.9	14.1	4.9	1.0	7.8	4.0	11.9	11.5	25.8	7.3	3.3	37.0	27.5	4.1	4.9	6.2	19.6	9.7	6.8	19.4	18.1	3.5	3.7	2.3	5.4	5.7	11.8	11.0	1.6	7.1	32.1	4.1	2.3	1.7	5.4	3.9	1.6	11.1	7.5	0.9	2.3	7.7	2.7	15.4	2.0	0.7	4.6	7.0	8.2	0.2	2.0	1.5	1.1	8.5	1.2	5.2	24.9	2.4	0.4	3.7	1.5	0.7	3.8	3.5	0.8	25.8	5.2	1.3	0.8	0.9	0.6	1.5	1.8	4.9	2.4	1.1	7.0	3.0	0.1	0.9	7.8	2.3	1.6	14.6	2.8	0.9	4.4	2.4	4.9	4.4	2.4	0.4	1.5	2.9	2.0	1.4	0.1	3.8	3.0	1.6	0.9	4.0	4.5	2.0	2.1	0.1	0.5	0.0	4.0	1.7	4.2	5.0	5.0	4.6	4.0	5.1	3.9	3.6	3.9	3.3	4.9	3.5	32.6	57.7	3.7	3.6	19.7	1.7	0.7	0.5	1.2	3.9	2.3	2.0	19.4	0.0	1.3	3.7	0.0	3.7	13.3	0.4	0.0	1.1	18.7	0.4	5.1	28.4	4.8	0.0	17.7	3.1	15.8	35.7	18.8	1.0	4.5	7.8	24.7	2.2	4.4	1.7	36.5	0.8	6.1	15.5	6.3	4.9	4.4	14.2	7.2	56.2	3.6	0.0	19.6	14.1	5.7	2.4	1.2	4.5	10.2	0.7	4.9	0.6	0.8	0.9	59.2	18.2	46.5	1.3	2.1	0.7	2.4	13.1	14.1	4.6	0.5	0.9
GTF3C3	"TFIIIC102, TFiiiC2-102"	ENSG00000119041	"General transcription factor IIIC subunit 3"	Q9Y5Q9	2	196763035-196799725	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069179			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA069179: AB_2686099"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (1.92e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.62e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.08e-2)"	11.0	10.9	18.1	9.6	20.4	36.8	19.5	25.1	23.1	10.9	23.8	10.8	10.2	12.2	15.1	11.4	11.9	19.6	10.0	19.8	19.9	9.5	12.9	10.5	18.8	21.7	19.0	13.8	13.1	13.6	9.0	12.5	25.9	10.2	13.1	18.6	9.7	10.0	13.6	20.9	10.8	14.3	17.9	13.8	12.1	13.9	19.5	13.4	15.1	7.3	10.9	11.6	9.4	31.8	14.4	19.2	28.4	22.2	13.1	19.4	28.0	26.2	16.3	24.7	25.0	41.4	23.0	29.8	15.9	15.7	24.1	19.2	24.4	23.3	28.7	35.0	26.6	37.2	59.9	38.6	21.8	32.8	28.9	25.8	21.4	17.8	25.0	21.9	22.6	25.7	45.6	54.6	14.9	34.0	28.6	29.2	16.9	16.9	29.3	24.4	20.7	19.8	17.6	43.2	22.6	20.5	16.7	14.6	17.8	35.9	15.4	21.1	15.0	21.2	15.1	16.7	19.3	26.0	34.4	22.2	21.8	24.4	16.9	8.4	4.7	4.4	3.9	3.1	3.5	4.8	3.5	4.0	2.8	6.8	4.2	4.0	4.4	4.8	5.8	4.3	4.8	2.3	18.1	20.4	25.1	23.1	19.8	19.9	21.7	19.0	25.9	17.9	19.5	31.8	17.4	22.4	16.0	19.2	11.6	4.0	12.2	16.6	10.2	18.1	8.8	8.8	35.8	7.2	21.4	14.7	18.8	15.3	18.1	7.7	13.7	12.4	4.4	18.2	17.4	17.0	12.5	19.1	24.7	12.3	12.6	12.9	11.2	13.3	14.0	24.7	12.8	8.2	13.5	0.0	29.8	10.1	16.2	12.7	5.0	4.6	13.4	11.8	7.2	27.2	22.0	12.5	9.2	23.1	38.5	14.7	6.4	10.9	16.3	8.4	12.9	10.9	37.2	15.6	6.6	10.1	13.6	44.7	24.8	11.6	5.5	15.7	12.2	18.2	11.9	9.4
HABP4	"IHABP4, SERBP1L"	ENSG00000130956	"Hyaluronan binding protein 4"	Q5JVS0	9	96450169-96491336	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.3"	"Group enriched"	"Detected in many"	10	"Early spermatids: 224.6;Late spermatids: 808.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055969, HPA062366"	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Cytosol	"HPA055969: AB_2682991, HPA062366: "	"unprognostic (1.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.10e-7)"	"unprognostic (2.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.62e-2)"	21.9	12.8	62.7	7.0	70.1	1.8	16.8	55.1	73.3	16.1	40.8	19.2	3.0	13.5	7.0	7.6	13.5	8.8	28.1	62.3	63.9	27.0	7.6	10.8	8.3	66.2	65.4	15.6	6.6	12.9	22.6	3.5	66.1	12.5	4.2	16.0	6.2	11.1	16.8	9.5	10.4	9.7	59.5	7.5	12.5	43.9	61.3	4.6	13.7	13.4	5.3	18.4	13.0	68.9	14.8	16.6	20.6	22.3	44.7	37.9	14.6	19.5	21.8	14.5	15.7	24.9	24.0	7.5	9.4	29.4	45.9	10.6	17.4	3.7	11.6	9.0	10.3	2.9	7.8	42.0	22.7	0.7	3.0	15.5	6.7	16.5	13.0	21.9	10.4	8.4	3.4	21.6	26.4	15.2	0.3	4.6	9.6	20.5	15.8	7.6	17.9	0.3	24.8	6.4	13.0	8.8	10.6	6.2	32.5	15.2	4.5	3.2	17.8	19.8	4.6	36.6	16.8	13.2	14.0	3.3	15.9	5.9	29.8	0.0	0.0	0.0	0.5	0.1	0.5	1.9	1.6	1.3	0.0	1.1	1.1	1.1	0.1	0.4	0.3	0.0	1.3	0.2	62.7	70.1	55.1	73.3	62.3	63.9	66.2	65.4	66.1	59.5	61.3	68.9	22.2	0.0	7.4	27.1	5.9	11.5	10.8	0.9	4.0	22.6	3.8	6.9	11.0	14.3	5.5	18.4	0.0	2.5	5.5	0.9	17.6	4.7	224.6	7.3	9.0	14.6	13.1	0.8	47.4	5.8	7.4	13.3	1.5	8.1	1.3	13.0	15.0	6.3	6.6	23.5	33.2	0.9	4.1	1.3	9.3	808.8	13.7	6.0	17.8	10.3	2.7	22.2	3.1	18.6	37.5	6.3	0.0	23.7	5.1	10.0	1.1	43.7	1.8	15.6	6.6	5.8	26.4	26.8	15.4	0.9	8.0	1.4	13.3	3.0	1.3	6.0
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594392	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	8.7	8.2	15.9	13.2	19.5	12.7	6.1	18.8	22.0	7.0	1.0	11.3	7.3	7.5	5.2	7.7	6.6	9.9	10.5	15.9	9.9	5.2	4.1	9.6	17.2	9.2	3.5	7.0	6.6	8.9	7.7	8.1	9.2	6.0	7.9	10.7	5.6	6.3	8.4	4.1	8.8	9.8	4.7	16.7	7.3	5.9	5.9	20.3	5.9	11.6	12.5	10.8	5.5	10.1	12.7	11.0	18.2	14.8	10.4	11.1	19.2	10.0	9.4	10.9	11.3	14.6	11.5	7.8	13.3	15.4	14.0	12.6	12.6	11.1	8.5	27.7	10.9	9.5	9.7	6.5	8.8	17.3	34.3	9.9	9.9	10.6	9.0	9.5	15.1	44.9	8.5	67.4	8.3	16.2	26.3	16.8	17.6	7.4	11.3	12.0	12.5	51.9	5.6	41.6	12.8	15.7	12.1	10.1	9.5	18.7	4.8	13.8	14.3	12.7	17.9	10.1	7.5	50.2	31.1	5.8	10.5	16.2	11.5	1.1	1.0	2.3	2.8	2.2	3.3	0.4	1.6	1.8	1.1	0.1	2.2	2.5	1.1	3.2	3.4	3.3	0.9	1.0	15.9	19.5	18.8	22.0	15.9	9.9	9.2	3.5	9.2	4.7	5.9	10.1	14.6	6.4	13.1	50.9	11.2	8.0	6.4	2.8	9.1	49.7	5.3	4.2	12.6	2.8	7.8	5.5	8.4	10.2	64.6	4.1	3.9	4.0	13.5	6.2	9.1	14.2	5.4	7.2	150.5	1.5	8.7	9.9	6.6	6.3	0.0	22.4	14.3	3.4	10.5	33.7	124.4	5.6	4.1	36.4	18.4	10.9	9.3	25.3	10.6	73.1	26.8	8.4	71.1	55.8	26.1	3.8	2.5	12.0	48.6	5.9	1.2	3.3	5.1	14.1	6.6	9.9	12.4	8.6	14.0	5.2	6.1	9.4	48.3	9.4	3.6	6.8
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"Adipocytes: 157.8;Endothelial cells: 143.8;Hepatic stellate cells: 158.1;Muller glia cells: 206.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 27.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 74.8;TIME: 83.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		11000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear membrane"	"CAB004028: AB_2212507, HPA073577: "	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	41.6	11.7	2.7	4.3	3.8	0.0	26.1	2.8	4.1	14.8	10.4	6.3	2.2	39.5	2.9	4.0	17.9	5.6	20.6	2.1	2.8	15.7	9.2	23.5	2.8	3.2	3.6	5.2	6.2	8.6	11.0	30.9	3.5	11.7	1.0	16.4	5.3	10.0	6.5	5.9	7.5	7.5	3.3	4.4	8.4	1.8	4.5	1.0	34.4	4.6	1.0	8.6	7.5	3.4	0.0	0.0	4.4	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	8.5	0.0	0.0	0.9	0.0	0.0	0.4	0.2	74.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.8	2.8	4.1	2.1	2.8	3.2	3.6	3.5	3.3	4.5	3.4	157.8	0.0	4.9	0.0	1.4	2.5	0.5	0.1	1.8	11.7	1.3	2.5	9.4	1.5	18.4	0.0	0.0	0.1	0.8	0.0	0.0	0.5	0.8	0.4	2.6	143.8	0.0	2.7	0.1	0.0	0.1	8.3	0.0	0.8	2.5	0.0	158.1	3.3	0.4	0.0	1.3	0.0	0.0	10.6	2.1	0.9	0.0	1.2	7.2	7.5	0.0	206.6	0.0	0.0	6.1	0.5	0.0	0.4	1.3	0.5	0.0	0.0	3.9	7.9	0.0	0.9	7.5	0.3	0.9	0.8	2.7	0.1	0.6	1.6	0.0	1.4
KLHDC2	"HCLP-1, LCP"	ENSG00000165516	"Kelch domain containing 2"	Q9Y2U9	14	49768130-49786385	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000628	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nuclear bodies"	"HPA000628: AB_2666051"	"unprognostic (2.65e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.52e-3)"	"unprognostic (4.54e-2)"	"unprognostic (9.72e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-3)"	"unprognostic (6.77e-3)"	"prognostic favorable (2.75e-10)"	"unprognostic (2.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.34e-2)"	21.5	22.3	12.8	8.6	13.3	10.1	19.6	13.7	16.1	18.8	15.0	23.8	18.4	20.7	14.8	15.0	17.0	13.8	38.0	14.4	14.0	34.1	49.1	14.5	10.9	12.4	12.3	25.1	30.3	16.8	17.7	12.7	13.9	18.5	18.0	23.9	20.1	20.1	53.0	18.8	21.6	14.1	13.3	12.3	24.4	23.3	12.6	15.2	28.2	38.2	10.5	22.3	16.2	14.9	14.7	12.2	22.5	11.0	31.7	27.5	23.7	15.0	28.8	18.8	19.0	7.1	19.6	29.1	20.4	27.4	10.8	12.8	13.9	13.9	15.9	20.1	14.7	9.1	8.6	17.0	23.1	19.6	7.8	28.6	23.5	8.6	16.9	23.1	17.4	24.6	11.8	21.5	15.1	17.3	20.1	8.6	16.6	17.0	34.8	15.3	24.0	18.1	8.6	31.2	27.4	22.0	25.1	46.4	17.1	17.2	17.8	7.4	14.9	17.2	13.3	13.7	7.8	29.0	19.7	17.1	9.7	10.0	9.2	12.3	9.1	19.9	11.1	6.1	13.8	18.2	16.8	17.4	9.0	19.0	23.5	15.8	8.4	16.8	5.8	6.8	18.0	12.3	12.8	13.3	13.7	16.1	14.4	14.0	12.4	12.3	13.9	13.3	12.6	14.9	40.6	41.7	52.4	30.3	42.1	48.9	53.5	64.8	53.5	65.1	48.6	40.9	9.3	77.2	53.9	47.8	50.1	102.5	40.7	68.9	107.6	59.8	96.8	44.8	41.9	36.4	57.2	47.8	30.6	85.8	68.6	51.2	67.2	38.7	30.4	62.8	45.3	91.8	33.2	65.6	35.4	75.3	63.1	28.7	33.6	27.1	81.4	26.5	39.2	18.7	36.3	73.9	54.6	28.1	33.1	54.8	78.9	77.5	74.5	53.9	143.9	170.1	27.8	98.1	65.7	46.3	90.5	238.7	93.2	42.7	66.3	82.4	44.9	54.7	78.9	55.5
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 248.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062236	Enhanced		Supported	"Nuclear membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	28.6	9.1	8.8	53.2	9.7	95.7	17.1	9.3	11.9	27.3	9.2	61.4	40.7	47.0	44.4	29.7	31.8	21.7	10.0	8.5	10.1	19.4	47.3	19.2	81.6	12.0	9.8	19.4	16.9	5.6	6.5	27.6	11.2	23.8	46.2	5.3	11.1	36.7	9.8	13.8	39.9	41.4	10.2	41.5	28.2	20.5	9.5	105.5	11.8	12.8	70.7	32.3	23.0	13.1	122.2	42.0	154.9	69.3	64.8	39.7	77.3	31.2	39.2	65.0	69.0	87.2	207.2	248.4	66.6	32.8	38.6	88.8	114.2	32.9	98.5	142.2	107.1	61.4	40.4	81.5	39.9	274.7	105.5	34.3	21.3	58.9	52.0	33.1	82.9	117.4	189.6	164.6	44.4	16.3	254.9	156.6	140.6	121.8	14.2	164.9	141.4	234.0	75.6	52.7	40.6	53.4	52.7	39.6	26.6	68.2	53.3	181.0	50.5	17.6	91.7	49.3	115.9	56.6	83.0	274.5	24.3	120.5	61.2	83.6	44.3	67.3	43.6	31.6	50.9	39.0	43.5	48.8	38.4	39.5	42.4	52.9	211.4	41.3	25.2	21.5	61.9	69.8	8.8	9.7	9.3	11.9	8.5	10.1	12.0	9.8	11.2	10.2	9.5	13.1	98.1	28.9	36.4	13.4	86.4	27.0	33.4	17.3	21.6	4.5	11.9	11.0	8.5	48.6	34.4	31.3	6.2	40.5	98.3	33.4	5.9	23.6	1.2	31.5	31.0	53.1	27.0	248.9	10.5	19.8	23.9	29.0	29.0	53.9	10.1	24.0	48.5	73.6	44.4	11.8	14.3	43.0	12.2	88.5	18.1	3.4	33.8	71.7	26.6	19.7	56.0	11.6	82.4	37.2	34.1	20.6	24.6	32.4	74.0	32.9	19.3	26.0	26.0	10.4	39.5	13.9	46.6	21.0	26.7	68.4	35.5	11.1	81.3	13.2	73.8	36.7
LEMD2	"dJ482C21.1, LEM2, NET25"	ENSG00000161904	"LEM domain nuclear envelope protein 2"	Q8NC56	6	33771202-33789130	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	40.5	45.8	46.0	35.0	47.9	63.3	39.6	53.1	50.8	52.6	44.6	45.3	31.9	44.1	29.7	50.2	45.9	30.0	46.7	43.9	44.0	51.5	49.9	51.2	45.4	52.0	47.0	53.7	54.5	39.3	56.5	38.5	47.9	51.9	30.0	29.7	43.3	31.3	37.4	51.8	50.1	30.4	46.3	70.1	44.9	45.5	47.2	46.1	53.0	28.1	41.6	43.8	44.9	54.4	36.6	40.5	67.3	66.1	37.6	40.3	50.9	39.1	59.7	48.5	50.9	30.6	37.8	33.8	53.5	55.6	136.7	62.0	39.4	52.1	34.0	35.9	36.6	12.7	45.8	40.3	78.4	26.1	42.6	44.3	96.5	51.6	88.1	80.0	52.8	43.9	36.3	38.3	42.8	30.8	48.6	64.1	39.2	53.5	23.2	31.8	27.8	28.3	52.0	50.5	47.8	37.8	23.4	74.0	52.6	68.0	49.5	70.7	24.6	67.8	26.3	36.6	46.5	49.8	43.0	24.0	26.7	40.3	83.0	1.6	1.7	3.2	2.3	1.5	2.9	2.2	2.5	2.3	1.7	2.3	2.0	2.3	1.4	1.5	2.1	2.9	2.8	1.2	46.0	47.9	53.1	50.8	43.9	44.0	52.0	47.0	47.9	46.3	47.2	54.4	19.8	3.2	9.0	16.0	17.4	10.8	13.4	7.9	14.2	18.6	10.0	7.1	10.0	8.6	5.2	9.2	18.8	24.9	18.6	24.3	1.9	9.4	24.9	7.5	10.1	18.5	5.4	8.6	14.5	6.8	36.6	12.2	15.3	10.6	12.7	16.6	12.5	7.7	17.5	43.7	17.4	17.7	6.1	14.5	12.4	44.2	10.5	13.5	12.4	14.0	9.4	14.0	13.4	14.6	18.2	13.2	20.1	16.1	11.9	14.6	14.8	6.6	7.2	13.1	19.7	12.7	15.2	24.6	7.4	8.9	10.2	29.8	15.2	12.5	15.9	13.2
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169583-65248355	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: AB_2686821"	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	9.3	7.3	6.6	10.5	8.0	20.8	10.6	12.2	9.4	8.6	6.9	10.4	9.6	12.2	8.8	8.1	9.3	6.9	7.2	8.5	6.3	9.6	9.5	9.3	13.5	6.0	6.9	11.9	9.8	14.7	5.3	7.2	6.4	9.4	10.0	16.6	9.3	7.7	8.7	8.0	9.4	8.3	6.9	11.4	9.7	15.6	6.9	13.6	10.6	9.6	12.3	8.9	8.1	7.7	19.7	10.9	17.1	17.2	11.8	13.6	11.7	22.4	12.0	11.0	9.5	13.7	12.4	53.2	14.1	13.9	8.5	25.8	18.5	16.0	15.9	12.8	21.4	21.7	10.2	10.5	9.0	33.4	15.1	9.9	16.9	13.1	17.6	15.5	13.1	14.6	28.9	24.6	15.6	11.5	17.5	17.3	23.5	8.9	11.1	40.6	16.8	26.8	13.8	21.4	17.8	10.9	22.5	22.7	14.0	16.4	22.6	26.0	18.1	13.4	14.3	12.7	15.7	17.5	17.7	32.3	11.2	16.1	16.8	1.0	0.7	1.4	1.5	0.6	2.0	1.8	2.0	2.0	1.0	1.9	1.9	2.1	0.8	1.6	0.9	2.1	1.9	0.7	6.6	8.0	12.2	9.4	8.5	6.3	6.0	6.9	6.4	6.9	6.9	7.7	21.7	38.5	21.0	29.7	29.0	32.1	19.4	10.4	14.8	20.1	15.3	11.3	14.7	8.6	13.5	11.0	18.8	8.0	32.7	20.2	0.0	10.3	2.1	16.3	18.0	17.4	14.9	16.8	50.0	13.1	4.6	18.5	13.3	19.8	22.2	12.5	14.6	13.3	6.5	16.8	58.2	13.7	12.2	13.7	16.4	3.2	15.8	16.4	17.8	49.6	16.1	20.3	17.5	53.3	52.7	14.6	14.5	12.4	23.6	18.9	7.8	4.3	19.3	21.5	6.6	23.5	19.2	43.3	35.3	17.6	39.1	14.4	21.9	13.7	11.8	22.9
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 92.5;Erythroid cells: 67.3;Extravillous trophoblasts: 68.2;granulocytes: 93.6;Late spermatids: 72.1;monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757, CAB079954"	Supported		Supported	"Nuclear membrane"		NA	NA		2100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: AB_2665863, CAB079954: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	4.2	1.6	1.9	26.6	1.8	34.0	2.9	9.8	2.1	3.7	0.5	14.9	11.2	2.8	0.5	14.2	1.8	3.4	1.5	1.6	3.3	3.5	4.9	6.0	34.8	2.9	2.3	2.2	2.4	0.7	2.0	6.7	2.4	1.6	13.0	6.4	3.4	1.6	1.0	8.6	14.2	3.5	2.1	13.3	7.9	2.2	2.3	49.2	1.6	1.4	29.2	6.8	4.8	1.8	132.7	43.4	131.6	126.6	3.3	9.3	170.6	60.6	17.8	66.1	71.3	113.4	107.2	229.4	103.2	21.4	31.5	72.4	90.9	42.1	72.2	162.9	112.1	147.5	49.1	67.2	1.4	176.6	95.6	3.0	0.9	35.2	16.0	12.8	54.9	92.0	87.1	86.3	46.6	109.7	322.8	347.5	99.0	54.1	60.0	152.6	259.4	93.1	36.6	59.6	151.4	80.3	98.4	41.7	36.6	45.2	76.2	202.0	46.9	48.7	132.0	36.6	131.3	56.8	46.4	197.3	25.0	247.1	73.8	1.4	14.4	4.8	2.1	5.6	1.6	4.2	4.3	2.8	15.3	2.9	3.1	2.8	9.3	2.4	1.5	4.6	12.4	6.4	1.9	1.8	9.8	2.1	1.6	3.3	2.9	2.3	2.4	2.1	2.3	1.8	3.4	0.0	4.3	0.3	20.1	5.0	1.9	2.0	8.0	6.4	4.3	5.1	1.6	4.3	3.3	0.0	8.4	39.4	56.0	7.7	1.9	1.8	92.5	3.9	4.8	8.8	6.1	67.3	6.8	0.8	68.2	8.1	11.7	7.6	93.6	23.9	3.6	3.1	21.8	5.0	9.1	19.3	0.0	13.1	17.9	72.1	2.1	27.9	1.8	1.9	59.5	3.8	13.4	5.5	1.1	1.1	8.4	0.4	50.6	1.1	3.8	2.1	1.9	17.5	0.0	2.5	7.3	3.4	8.9	27.3	5.4	4.7	34.2	3.0	35.8	1.4
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456959	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 220.2;Extravillous trophoblasts: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"		NA	NA		110000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear membrane"		"CAB022593: , HPA047863: AB_2680189, HPA062477: AB_2684776"	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (9.53e-5)"	"prognostic unfavorable (9.34e-5)"	"prognostic favorable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	9.7	10.1	8.9	15.3	8.6	17.3	7.7	11.5	9.8	11.9	6.4	13.1	10.9	11.9	2.4	32.1	10.7	3.4	10.6	8.5	10.1	9.5	6.0	11.2	12.8	8.7	9.0	13.4	8.1	3.6	12.3	14.6	8.4	9.8	6.2	3.5	9.1	4.9	14.9	10.6	12.2	5.5	8.0	12.3	10.4	10.9	10.5	23.1	8.7	5.2	10.5	10.0	12.4	8.0	181.5	114.0	80.8	105.7	17.3	27.2	107.5	119.2	57.7	117.7	88.8	152.0	75.6	83.5	47.8	55.9	68.1	185.6	72.4	84.8	60.0	102.4	86.3	66.4	40.3	119.8	20.9	93.5	64.6	24.5	21.4	63.4	49.7	22.0	60.9	76.2	117.8	51.9	56.4	105.4	107.9	51.8	154.0	97.8	98.6	150.1	102.4	70.0	33.7	89.8	118.7	68.8	99.6	65.6	39.6	44.7	65.9	95.7	85.1	112.5	116.6	174.8	180.6	45.6	41.8	83.5	91.3	88.5	148.3	0.0	0.6	0.8	1.0	0.6	1.6	0.4	1.1	1.0	0.8	0.9	1.1	1.3	0.0	0.9	2.1	3.5	0.4	0.6	8.9	8.6	11.5	9.8	8.5	10.1	8.7	9.0	8.4	8.0	10.5	8.0	8.6	3.2	4.2	2.6	9.4	20.6	14.8	7.9	10.2	8.2	8.8	8.1	5.7	2.8	5.3	5.5	8.4	30.4	9.7	17.5	9.8	7.0	220.2	7.7	14.9	12.7	6.0	19.6	3.0	11.8	81.6	14.3	14.3	11.7	4.5	31.4	8.2	2.7	21.2	13.5	3.9	15.1	6.1	6.8	18.2	31.4	9.3	10.3	1.8	3.7	12.2	9.4	11.3	2.0	3.3	12.7	9.1	7.9	25.5	24.4	12.7	4.9	5.7	10.8	13.1	14.3	11.2	8.6	15.0	30.0	20.0	13.8	11.4	12.0	23.1	19.2
MAD1L1	"HsMAD1, MAD1, PIG9, TP53I9, TXBP181"	ENSG00000002822	"Mitotic arrest deficient 1 like 1"	Q9Y6D9	7	1815793-2233243	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 316.9;Late spermatids: 685.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003635, CAB015338"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"CAB015338: AB_627901, HPA003635: AB_1853472"	"unprognostic (1.85e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.26e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.57e-1)"	9.4	6.0	6.2	11.1	8.3	14.9	9.0	4.6	8.4	11.4	5.1	7.7	6.0	9.3	2.5	9.2	7.4	4.8	8.8	5.6	6.7	6.5	6.4	10.2	17.8	7.8	6.6	7.4	5.6	4.1	7.1	5.0	7.6	8.2	3.4	4.0	7.3	5.6	13.6	14.5	9.7	5.3	5.5	18.2	6.6	10.7	7.0	15.3	8.6	5.0	10.7	8.3	10.1	9.4	37.2	15.5	16.5	30.1	11.1	11.2	26.5	25.6	13.0	26.0	20.7	28.5	21.5	23.4	10.4	14.7	39.9	28.5	12.4	18.3	15.7	11.1	17.8	30.1	19.4	45.0	15.7	21.1	55.1	13.9	13.3	28.8	14.0	6.3	14.9	13.7	30.3	17.4	10.3	45.4	8.7	61.0	30.7	5.8	20.5	38.5	16.7	17.5	12.7	18.7	10.7	33.4	20.0	24.9	65.2	11.2	17.1	48.9	17.6	21.8	60.0	62.3	26.0	30.3	31.4	27.3	18.1	60.6	80.3	60.4	36.2	25.4	71.3	62.4	66.6	54.6	69.2	72.3	63.4	63.0	92.0	66.0	8.6	22.7	60.1	26.0	131.5	53.6	6.2	8.3	4.6	8.4	5.6	6.7	7.8	6.6	7.6	5.5	7.0	9.4	9.3	3.2	10.4	12.1	33.8	17.6	13.9	14.0	15.4	8.3	6.2	6.5	7.4	14.3	11.9	7.3	10.4	16.2	35.7	12.4	15.6	12.3	316.9	5.5	6.7	10.7	32.4	19.1	20.9	11.4	16.3	11.4	11.7	6.9	41.8	15.5	6.4	36.4	39.6	23.5	24.4	9.4	16.2	31.4	84.1	685.9	12.5	28.2	37.4	21.5	25.7	24.3	47.4	16.1	32.4	16.5	7.9	10.5	14.9	9.4	5.4	15.2	6.6	13.9	19.7	11.2	10.2	60.3	33.8	9.3	21.5	24.5	43.1	17.5	8.8	9.7
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	15.0	22.4	12.8	8.6	16.3	19.1	19.2	21.9	19.0	18.6	2.9	15.0	9.3	19.5	20.6	14.1	15.6	14.2	9.9	14.7	10.5	16.8	17.5	12.1	12.4	10.6	11.4	18.5	13.7	20.5	5.3	21.1	10.9	19.3	18.7	20.0	11.5	16.4	4.3	16.4	11.6	16.4	11.3	10.5	15.7	21.3	15.5	7.5	18.3	2.4	11.6	15.3	10.3	17.7	12.4	11.1	21.5	22.9	30.9	28.9	17.9	38.1	19.4	28.4	33.1	9.6	19.0	9.2	7.2	41.8	19.9	11.2	18.5	22.8	25.5	28.2	25.5	30.0	16.0	10.8	39.3	6.2	24.3	22.5	19.6	25.3	18.1	27.4	23.1	21.7	18.6	7.6	28.5	13.4	13.2	7.5	7.8	19.9	21.6	6.5	12.5	6.4	32.1	9.2	17.6	19.2	18.5	17.5	16.1	19.2	20.4	13.4	23.9	18.5	14.4	31.4	11.2	45.6	18.8	15.7	21.2	13.6	15.1	2.6	1.7	1.5	2.2	3.5	1.8	1.3	1.5	2.4	1.9	1.9	1.0	2.0	1.5	1.7	4.0	2.0	3.1	1.5	12.8	16.3	21.9	19.0	14.7	10.5	10.6	11.4	10.9	11.3	15.5	17.7	17.3	22.4	14.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	9.7	7.4	0.0	0.0	3.7	14.7	0.0	18.7	10.7	0.0	19.6	11.6	0.0	8.2	18.1	5.2	0.0	0.0	0.0	8.3	17.0	7.5	0.0	9.7	1.3	11.5	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	9.0	0.0	0.0	4.0	0.0	0.0	17.7	11.7	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	32.7	3.0	13.7	0.0	0.0
MX1	"IFI-78K, lncMX1-215, MxA"	ENSG00000157601	"MX dynamin like GTPase 1"	P20591	21	41420020-41470071	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 127.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 101.8;Extravillous trophoblasts: 77.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 820.2;BJ hTERT+ SV40 Large T+ RasG12V: 734.3;Karpas-707: 160.6;SK-MEL-30: 259.3"					"Low region specificity"	"Detected in all"			"HPA030917, HPA030918, HPA049724"	Approved	Approved	Supported	"Nuclear membrane,Cytosol"		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA030917: AB_10602010, HPA030918: , HPA049724: AB_2680862"	"unprognostic (3.62e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (9.95e-2)"	"unprognostic (8.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.81e-1)"	25.6	14.9	17.5	29.0	18.9	51.7	23.8	19.4	18.2	37.7	14.4	19.7	30.7	15.9	20.5	42.4	25.2	37.7	22.7	14.3	27.8	27.5	25.3	31.7	38.8	35.9	22.5	27.0	13.1	15.3	30.3	20.7	30.2	15.1	11.6	4.3	127.0	16.4	7.6	11.6	28.8	24.4	62.5	75.3	35.3	8.6	23.2	65.0	26.6	9.7	36.8	29.7	24.4	21.5	16.4	0.5	0.7	1.2	0.6	6.8	0.2	1.0	25.6	820.2	734.3	5.3	33.6	0.2	6.5	2.7	7.8	1.6	0.3	0.8	15.9	4.2	0.2	0.9	2.3	1.9	7.3	0.4	0.4	7.4	2.3	48.8	1.1	0.4	2.8	2.7	0.0	160.6	0.4	1.3	14.5	1.8	2.6	0.5	8.3	12.6	0.1	26.4	3.3	9.9	0.7	0.3	1.1	1.3	259.3	0.1	10.6	6.7	1.7	0.8	0.7	0.1	0.7	35.9	37.6	1.0	0.9	2.2	1.8	31.6	45.0	25.6	17.9	47.6	25.8	38.6	27.3	21.9	31.0	36.7	23.3	16.9	64.7	18.9	44.5	44.7	51.9	35.0	17.5	18.9	19.4	18.2	14.3	27.8	35.9	22.5	30.2	62.5	23.2	21.5	101.8	32.1	25.3	2.6	41.9	6.4	17.6	13.0	15.9	3.7	8.0	8.9	8.8	11.5	22.4	23.9	0.0	3.2	47.2	10.1	19.6	38.6	0.7	16.0	11.1	66.8	0.0	2.1	7.7	56.1	77.3	21.5	34.1	15.9	1.3	38.1	20.3	5.8	53.3	1.7	7.1	16.7	2.0	20.8	16.2	1.2	10.8	50.9	19.6	24.4	32.0	6.8	11.3	2.5	1.2	38.8	4.3	16.6	28.7	9.9	29.2	5.0	32.1	2.4	0.0	7.7	17.8	0.4	4.0	32.6	3.4	4.1	28.3	13.4	7.5	34.2
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765478-53838463	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	5.4	5.2	3.4	9.5	3.5	8.4	11.1	3.6	4.1	5.7	3.6	11.9	8.9	6.5	7.4	7.7	7.5	4.6	4.5	3.6	3.4	6.9	7.8	4.7	15.7	3.2	3.3	5.9	4.7	9.5	1.7	8.0	3.3	4.8	14.2	6.0	4.2	5.2	4.3	7.3	8.2	7.1	3.5	5.6	6.4	7.5	3.5	14.2	6.8	5.2	18.4	7.1	4.2	3.9	61.6	31.2	42.8	43.7	15.5	15.5	49.3	40.9	31.0	63.8	51.1	47.5	40.4	119.0	26.2	18.6	51.2	72.0	73.2	43.3	89.8	29.8	50.9	58.5	42.9	40.5	14.3	95.3	31.9	9.4	17.0	62.9	37.5	18.6	39.1	44.2	67.7	16.9	35.6	22.2	47.2	38.2	101.0	52.2	49.9	52.0	68.4	66.0	29.8	41.7	25.4	32.2	36.5	71.5	35.9	45.3	55.3	50.2	22.7	32.9	32.6	45.5	74.9	17.9	48.8	84.7	27.3	71.6	42.2	0.0	2.3	1.5	3.0	5.0	4.7	3.6	2.8	2.7	2.6	2.8	5.3	4.1	0.1	3.1	3.3	2.3	3.4	2.4	3.4	3.5	3.6	4.1	3.6	3.4	3.2	3.3	3.3	3.5	3.5	3.9	4.4	6.4	6.3	12.4	8.7	10.1	6.4	9.0	12.0	4.5	10.1	6.3	8.1	4.3	5.4	5.5	2.1	11.5	5.9	7.9	0.0	8.5	2.3	5.0	5.6	6.1	0.0	19.4	13.8	9.1	20.2	6.3	8.6	4.6	7.6	21.5	5.3	7.1	11.8	3.3	11.0	10.3	16.2	8.2	8.9	2.1	2.8	7.1	7.2	13.1	4.7	3.3	3.1	11.6	19.4	7.0	5.8	3.4	20.1	8.9	2.9	4.5	5.5	2.9	6.6	6.3	15.7	11.8	14.3	18.2	8.5	6.8	6.7	4.3	18.2	6.5
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 60.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	7.6	4.7	0.4	0.6	0.4	1.7	6.1	0.4	0.4	13.0	0.3	6.7	0.2	13.5	0.3	8.8	8.2	0.3	5.3	0.4	0.4	4.4	2.9	7.8	1.0	0.5	0.4	8.1	5.2	0.3	1.7	0.9	0.4	4.8	0.5	0.3	4.2	0.9	2.1	8.1	6.5	1.1	0.4	7.3	3.9	10.9	0.5	1.5	4.8	0.5	1.1	6.9	9.1	0.4	3.0	2.8	5.2	3.7	0.8	2.8	0.6	1.5	2.9	4.7	4.2	3.1	2.1	5.1	1.0	3.1	2.1	4.6	2.9	5.0	1.3	7.1	1.5	3.1	4.0	4.0	1.0	2.4	4.6	1.7	1.8	4.6	1.7	1.6	3.7	4.1	2.8	4.5	3.2	2.7	3.9	2.6	1.1	3.3	1.7	9.2	3.5	6.2	2.1	1.5	1.9	1.7	1.7	2.1	1.0	1.6	3.4	2.4	1.5	4.3	2.3	2.4	2.8	1.6	3.3	1.8	0.6	6.5	5.6	0.3	1.6	0.1	0.4	0.5	0.3	1.8	0.4	0.6	1.4	1.7	0.2	0.2	0.6	0.4	0.2	1.6	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	12.1	3.2	2.0	0.7	12.9	9.8	6.3	9.6	5.7	1.7	3.0	7.5	1.9	12.8	4.9	1.8	2.1	23.0	5.1	1.6	3.9	12.2	13.5	1.0	8.4	12.3	1.2	9.2	0.3	5.6	28.1	9.0	1.5	2.7	12.7	5.0	4.6	1.0	17.6	3.3	0.4	3.4	2.0	20.5	18.9	60.1	5.6	12.8	3.6	1.0	25.6	1.2	7.2	0.5	0.3	4.8	0.5	6.0	5.5	1.7	0.5	1.0	0.4	1.9	6.6	7.3	11.6	4.4	2.1	14.6	6.3	5.1	9.9	3.9	6.3	4.3
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706925	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	16.5	10.3	5.4	18.2	6.1	45.6	16.7	12.5	7.4	15.2	10.1	12.8	10.1	17.0	11.6	16.2	15.0	14.9	11.2	6.2	6.3	13.1	23.4	13.9	23.9	6.1	7.1	18.6	13.2	17.9	9.2	18.9	6.4	12.0	13.1	15.7	12.0	13.1	25.1	15.9	12.8	14.4	6.3	17.8	11.6	26.7	6.8	25.2	13.8	19.5	27.6	18.7	14.5	9.7	55.6	27.2	57.7	50.8	24.9	29.3	57.8	42.3	39.3	61.8	65.7	45.5	24.9	104.3	69.7	37.7	51.9	39.4	68.1	41.0	99.0	56.2	52.7	55.6	29.4	47.0	18.6	81.0	50.2	31.0	32.5	64.9	46.5	23.6	37.0	34.5	131.7	32.5	41.9	29.5	60.5	50.1	45.6	20.8	29.5	80.1	74.2	97.9	27.3	53.1	64.6	37.5	36.0	58.3	36.2	90.5	37.8	29.0	34.8	63.2	36.2	30.2	66.7	41.8	63.8	102.8	15.6	36.8	76.1	1.2	1.3	3.2	2.8	1.2	3.7	1.7	3.5	3.4	1.9	2.1	2.1	2.1	3.4	3.0	1.8	1.1	1.7	1.3	5.4	6.1	12.5	7.4	6.2	6.3	6.1	7.1	6.4	6.3	6.8	9.7	28.9	19.2	23.2	39.8	31.4	76.3	37.9	11.1	51.2	14.2	32.5	18.7	14.3	11.5	11.9	16.5	16.7	20.9	24.0	19.4	1.9	8.8	27.3	69.3	56.8	23.3	20.9	44.0	53.0	6.0	21.7	31.8	23.4	91.0	3.8	17.7	13.6	30.7	17.5	16.8	48.8	13.6	12.2	15.6	36.7	19.6	17.4	27.5	21.4	47.8	12.7	7.2	20.6	37.2	50.5	13.4	7.0	14.7	27.9	41.7	10.1	9.8	23.4	12.7	13.1	55.1	26.4	30.4	22.3	51.8	79.3	23.9	35.8	11.7	16.8	35.1
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 119.2;Late spermatids: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes		31000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.9	29.4	14.2	37.3	13.2	27.1	18.9	18.4	15.9	22.5	14.0	22.5	23.7	27.6	11.0	25.0	24.8	18.4	20.4	13.9	15.7	18.5	31.7	19.4	38.3	15.5	14.2	29.8	21.0	18.0	22.8	22.4	15.8	19.9	21.1	11.1	21.8	17.5	33.7	23.4	24.3	27.7	13.6	29.8	19.4	50.4	14.7	41.9	16.3	24.5	37.7	24.6	20.1	16.9	126.7	115.5	88.8	74.0	26.0	30.0	79.7	92.8	65.8	99.3	98.8	79.8	71.9	141.2	51.7	60.8	65.9	73.6	108.3	62.1	96.1	211.6	112.0	109.8	59.4	72.6	30.9	108.8	106.8	28.6	44.8	62.0	54.8	44.1	71.5	82.7	138.6	135.5	69.2	59.7	196.7	83.6	82.0	117.4	102.8	170.3	99.9	120.3	46.9	93.7	96.2	68.8	88.2	103.8	46.3	63.8	78.8	51.5	53.0	150.2	85.3	49.1	155.4	96.3	295.9	132.5	62.2	90.1	113.9	12.3	33.4	6.7	17.7	34.7	24.1	15.1	17.6	19.6	33.1	14.9	11.9	15.4	5.2	22.0	20.1	29.0	17.2	22.1	14.2	13.2	18.4	15.9	13.9	15.7	15.5	14.2	15.8	13.6	14.7	16.9	16.8	25.6	22.4	0.0	28.4	34.2	16.5	16.0	21.1	11.4	23.7	26.0	15.4	21.5	18.3	9.2	6.2	37.0	24.4	24.9	9.8	23.7	113.5	19.2	23.9	27.7	21.6	39.1	0.0	16.3	48.4	19.5	20.4	25.6	23.4	30.4	30.4	13.3	49.5	63.9	0.0	27.0	16.2	36.1	119.2	315.1	24.8	41.5	21.4	0.0	77.1	19.1	22.6	0.0	0.0	22.9	22.8	23.0	23.3	24.1	20.6	16.1	19.2	16.3	19.7	18.0	16.0	71.0	39.3	20.0	32.0	21.8	24.4	17.2	33.4	16.6
PHF11	"BCAP, IGER, NY-REN-34"	ENSG00000136147	"PHD finger protein 11"	Q9UIL8	13	49495610-49528981	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA016566			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Nuclear membrane"	"HPA016566: AB_2669387"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.98e-6)"	"unprognostic (3.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (4.46e-7)"	"unprognostic (9.81e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.46e-4)"	28.3	39.5	17.2	33.4	18.8	37.0	32.3	17.6	23.6	29.1	18.2	28.9	25.3	24.0	28.5	23.2	23.0	26.4	21.3	16.4	19.6	33.1	22.4	28.9	43.4	21.2	19.9	22.6	25.1	16.5	16.1	23.9	20.3	26.3	22.0	9.1	39.7	24.6	13.4	27.2	27.6	27.3	20.5	39.3	28.9	13.4	19.4	31.6	34.3	11.3	39.4	28.4	27.4	20.5	12.0	4.9	1.7	0.0	23.5	44.4	14.7	28.5	32.5	40.0	42.1	0.0	28.3	29.2	7.7	32.1	26.5	8.2	10.4	9.8	23.6	59.2	8.8	14.5	9.5	12.8	29.1	10.5	21.5	27.0	15.4	16.2	9.0	16.4	26.0	23.6	3.1	12.4	30.3	9.8	33.7	24.8	5.6	7.8	3.3	32.2	0.0	8.9	36.5	21.8	1.0	0.2	7.6	15.9	0.4	2.1	9.3	23.6	23.2	9.7	3.8	14.0	8.2	8.9	4.9	18.1	20.0	14.9	14.9	26.3	42.4	31.0	42.3	54.1	49.1	40.7	53.6	50.6	39.9	35.0	43.1	48.5	51.3	30.0	51.4	34.8	78.0	42.6	17.2	18.8	17.6	23.6	16.4	19.6	21.2	19.9	20.3	20.5	19.4	20.5	48.0	16.0	28.7	15.7	48.2	22.6	35.1	41.0	29.0	4.4	26.8	25.4	19.5	27.1	40.3	36.8	0.0	26.1	54.6	15.2	35.2	41.1	35.9	38.3	48.9	35.0	4.2	18.5	11.1	42.3	46.4	32.6	23.0	34.9	24.0	30.3	31.1	22.3	41.9	11.8	11.7	15.6	26.4	40.9	31.5	56.3	32.0	46.6	12.4	27.2	66.8	17.0	58.7	16.1	23.9	38.5	8.5	31.6	35.7	35.4	21.4	29.2	63.4	5.0	46.0	26.5	28.7	24.2	6.0	27.1	20.2	21.1	60.4	23.1	15.8	35.8
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950370	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 452.5;Late spermatids: 661.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	12.9	8.2	10.4	12.0	11.5	11.8	12.5	15.4	13.0	10.8	9.4	10.9	6.0	11.8	7.3	11.9	9.2	10.8	11.5	11.2	10.4	7.8	8.2	10.0	14.2	11.6	11.1	13.2	6.8	12.1	5.4	11.7	11.1	10.3	8.4	14.4	9.5	10.8	32.3	8.1	7.8	11.6	9.5	14.7	8.2	11.8	11.8	14.7	10.2	17.6	13.9	10.5	8.5	14.7	18.1	14.2	24.4	36.0	17.3	19.7	22.5	20.2	19.1	19.8	17.2	41.4	13.1	30.1	17.9	27.1	24.4	10.7	22.6	28.2	24.1	13.7	9.6	55.8	26.3	15.6	17.3	27.2	20.8	15.6	38.8	21.0	32.2	23.5	22.1	21.0	23.3	18.8	23.1	10.8	27.6	15.9	12.0	11.9	17.5	20.0	35.9	17.9	15.9	12.4	21.9	17.9	36.0	41.0	18.4	21.8	32.6	20.0	31.1	43.7	9.9	23.0	21.0	17.2	22.0	21.5	32.2	19.5	22.9	17.3	11.2	33.1	12.4	11.5	13.6	15.0	12.5	14.6	10.6	11.1	14.0	14.7	25.9	16.0	16.9	9.9	7.2	9.0	10.4	11.5	15.4	13.0	11.2	10.4	11.6	11.1	11.1	9.5	11.8	14.7	51.2	38.5	41.8	28.4	131.1	34.8	76.6	52.5	31.3	77.4	49.8	53.5	62.2	31.5	43.5	38.6	98.0	106.7	191.0	16.3	37.2	29.8	452.5	39.8	41.6	46.3	36.0	37.6	49.7	19.9	52.5	53.6	23.0	34.7	142.4	41.2	47.2	18.2	54.5	114.4	49.5	27.9	30.5	62.7	84.3	661.6	35.8	87.1	39.2	62.8	62.6	50.0	105.0	34.2	55.2	24.1	26.5	53.4	76.9	60.0	14.0	24.8	50.2	80.7	19.7	65.5	50.6	60.4	47.0	29.8	28.3	22.3	127.8	30.1	28.8	55.4
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535005-154550400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	29.4	21.9	22.8	24.9	26.3	31.1	38.7	26.0	24.3	32.8	20.8	30.9	24.8	34.0	28.6	33.9	34.2	24.8	25.9	22.6	32.6	38.1	43.8	27.3	35.2	30.5	26.8	34.0	19.6	41.1	16.0	28.3	30.7	27.4	34.2	26.4	25.8	33.7	31.7	26.4	25.8	44.6	33.5	27.7	26.4	21.4	25.3	40.4	38.0	39.5	51.2	34.8	22.7	39.2	73.2	58.6	73.7	79.4	85.1	73.5	62.3	91.6	111.2	121.9	98.9	69.3	62.7	79.1	45.7	109.1	80.3	52.4	97.2	122.1	134.5	80.2	48.7	95.1	45.1	67.8	87.0	96.0	76.4	79.7	110.8	144.6	112.6	73.0	106.1	85.3	98.9	98.2	107.2	52.3	73.9	45.7	56.1	57.5	62.7	72.2	38.5	48.2	84.8	46.1	43.0	48.6	55.9	59.3	91.7	69.4	57.1	66.4	69.3	72.4	81.9	64.6	82.9	50.9	72.0	100.6	68.1	45.6	98.8	53.0	37.0	29.7	41.6	43.3	49.9	47.0	43.5	45.7	47.6	36.2	45.9	43.2	9.4	67.6	63.9	46.4	55.7	49.4	22.8	26.3	26.0	24.3	22.6	32.6	30.5	26.8	30.7	33.5	25.3	39.2	26.9	25.6	18.1	29.0	26.9	16.3	31.2	98.7	18.2	26.2	19.6	22.9	24.7	20.0	50.7	22.0	12.5	49.1	23.6	18.0	15.6	48.0	31.7	22.7	33.0	27.5	27.1	30.5	23.6	34.7	37.9	30.9	17.9	20.3	45.7	27.0	16.1	26.8	34.2	62.2	21.7	15.9	73.2	19.3	12.0	5.8	28.0	17.2	14.2	17.8	36.8	31.2	28.8	14.1	25.0	32.6	20.9	35.0	21.8	14.9	33.7	35.0	45.2	21.4	19.7	31.2	40.8	36.4	30.2	25.0	17.3	44.3	26.9	36.8	22.3	20.6
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	25.4	20.4	10.3	18.8	10.1	44.7	21.0	7.2	14.3	18.3	3.4	19.5	21.6	19.6	9.4	20.1	18.7	13.6	16.0	11.9	9.7	16.6	23.5	17.4	21.3	6.8	8.5	23.8	25.5	16.1	21.4	17.0	6.4	19.2	12.1	17.5	19.3	11.2	25.7	21.6	22.8	13.0	2.3	22.9	21.8	18.7	8.8	17.8	20.0	16.0	17.1	18.8	18.1	9.1	49.6	35.4	43.5	98.0	23.0	18.8	36.0	34.6	29.2	33.8	29.3	63.0	30.6	67.7	11.0	30.1	37.5	37.0	43.5	33.6	37.6	59.2	86.5	50.6	36.6	42.4	23.5	106.1	61.8	24.8	23.3	44.9	41.0	21.9	25.5	38.5	141.2	49.3	33.7	37.8	63.7	67.0	45.5	27.4	42.3	57.4	33.8	57.1	17.2	42.8	61.7	54.3	30.3	57.3	31.1	28.8	48.1	55.0	36.2	60.2	36.8	48.0	70.5	58.8	58.8	96.0	35.2	66.6	61.0	0.0	0.8	1.4	1.7	0.5	1.0	1.0	1.1	1.3	0.9	1.1	0.9	1.4	0.9	1.6	1.4	1.5	0.6	1.1	10.3	10.1	7.2	14.3	11.9	9.7	6.8	8.5	6.4	2.3	8.8	9.1	31.8	38.5	28.9	33.0	28.6	25.2	10.1	17.5	29.0	34.6	19.5	19.7	4.4	20.0	19.9	18.4	98.0	17.1	30.6	19.7	5.9	12.3	13.2	14.6	24.7	18.3	18.0	30.7	55.6	17.1	13.2	19.2	32.1	21.3	16.5	31.1	17.2	24.9	16.2	40.4	58.9	21.7	16.2	18.9	21.7	6.3	14.9	23.3	19.6	23.4	13.8	18.2	32.0	30.2	38.6	21.8	14.1	17.7	37.6	22.2	19.1	8.4	17.6	26.6	13.1	27.0	17.6	19.2	13.1	29.6	31.0	19.4	27.9	24.7	23.2	21.9
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 789.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		47000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	14.2	12.1	5.5	31.0	6.1	58.5	17.2	7.3	7.6	14.7	6.5	24.4	27.2	14.2	10.3	32.2	18.9	12.9	6.6	5.8	6.1	9.0	23.9	12.3	37.4	6.8	6.2	16.1	16.1	5.8	3.8	17.7	6.8	10.9	28.1	6.1	20.6	9.2	13.3	14.6	23.4	19.3	6.1	16.1	18.6	57.9	7.6	44.3	11.7	8.0	38.0	23.6	15.8	6.9	263.2	109.7	94.8	112.9	68.4	86.5	106.2	100.2	60.2	158.5	122.9	111.9	206.2	331.0	60.0	99.2	65.3	155.0	306.6	158.1	125.1	133.7	185.0	295.0	140.0	147.2	51.6	329.0	171.5	111.6	106.0	150.0	125.6	100.7	110.6	194.5	222.8	101.1	66.0	140.8	260.5	118.0	205.3	117.8	106.4	252.9	163.3	164.0	60.5	119.9	150.6	76.7	105.3	171.5	87.6	52.7	72.6	99.8	84.5	81.6	162.5	102.0	198.2	60.9	91.2	248.8	80.5	469.7	89.5	5.1	7.7	3.3	5.0	7.9	9.4	7.1	7.8	8.2	14.0	7.2	6.8	7.6	1.8	5.9	5.7	7.7	7.6	6.3	5.5	6.1	7.3	7.6	5.8	6.1	6.8	6.2	6.8	6.1	7.6	6.9	8.9	0.0	10.3	2.0	57.4	36.7	12.4	13.6	92.2	0.8	18.9	15.4	4.6	5.7	16.2	7.3	2.1	25.6	10.7	10.7	3.9	34.0	176.5	12.7	21.1	16.6	5.4	118.1	4.5	23.7	43.5	17.4	68.8	17.4	1.3	14.8	2.9	6.6	20.8	13.5	5.0	16.0	12.2	11.3	20.0	789.4	17.1	21.3	14.2	1.9	16.6	0.5	15.5	2.0	2.9	39.5	7.0	10.5	75.5	21.6	9.6	5.7	14.1	0.3	6.6	15.0	16.6	19.2	18.4	185.3	33.8	24.5	31.7	12.5	25.0	18.4
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 99.1;Late spermatids: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	18.9	17.3	12.4	18.7	13.3	32.5	17.9	13.4	18.4	13.4	13.5	18.4	17.5	12.4	13.7	18.5	14.5	13.7	13.7	13.9	11.7	18.2	16.6	16.2	22.4	10.4	13.5	11.5	14.1	22.3	10.7	19.9	11.5	16.0	18.5	26.6	13.5	13.9	21.2	17.3	18.8	15.7	10.8	19.7	17.2	33.6	13.7	25.3	17.5	15.3	23.8	18.3	10.1	11.5	33.3	28.9	10.7	15.8	36.3	28.2	23.9	56.3	45.2	35.4	24.9	36.4	41.8	59.5	27.3	53.5	31.5	43.7	30.2	45.3	58.4	57.7	19.2	64.8	23.9	31.3	56.6	68.7	65.4	26.8	86.1	39.8	84.2	34.3	36.0	25.5	25.6	0.1	55.3	30.0	38.5	39.8	8.7	59.5	19.8	30.4	41.5	23.7	43.6	43.3	19.3	11.9	29.9	54.0	54.1	24.8	20.7	66.3	47.6	30.4	18.6	41.1	40.5	14.8	14.9	34.9	27.8	38.4	40.7	46.6	14.5	34.7	15.6	18.4	17.1	18.6	17.1	17.7	17.6	12.5	16.8	14.8	9.7	20.0	23.3	9.1	19.2	14.2	12.4	13.3	13.4	18.4	13.9	11.7	10.4	13.5	11.5	10.8	13.7	11.5	20.9	22.4	19.8	6.8	26.5	30.5	12.7	17.5	14.8	22.2	15.1	10.5	13.5	5.7	19.7	7.3	25.0	20.2	31.6	24.8	33.2	15.1	99.1	37.4	16.9	23.0	11.4	24.8	14.4	15.4	21.8	16.1	17.3	19.9	26.6	12.1	17.5	12.3	17.5	30.3	17.2	15.5	24.4	22.4	19.9	191.0	14.6	23.0	14.2	12.2	21.6	24.9	29.9	11.6	16.2	24.4	20.1	11.3	18.0	22.0	15.8	21.4	40.1	43.2	26.3	21.6	14.5	83.5	29.1	19.2	29.1	42.1	26.2	17.1	12.6	23.5
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SMOX	"C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO"	ENSG00000088826	"Spermine oxidase"	Q9NWM0	20	4120980-4187747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 61.3"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 48.4;Erythroid cells: 89.7;Macrophages: 73.3;Pancreatic endocrine cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.0;myeloid DC: 2.4;neutrophil: 3.6;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;granulocytes: 3.6;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"A549: 119.6;Karpas-707: 201.7;RPTEC TERT1: 91.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047117, HPA060198"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Vesicles, Cytosol"	"HPA047117: AB_2679940, HPA060198: AB_2684220"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.33e-6)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (4.92e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.18e-2)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (4.08e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.07e-1)"	8.5	4.4	50.9	4.4	61.3	32.2	5.3	54.5	60.9	17.7	32.8	5.6	10.6	10.8	7.1	8.5	7.4	15.1	6.8	46.3	51.7	20.5	8.5	4.9	4.8	56.6	54.4	12.5	32.5	25.2	13.2	6.2	53.7	12.2	1.2	2.9	12.1	7.9	4.3	11.9	8.1	4.0	53.0	6.4	20.1	5.8	55.5	4.3	6.8	2.8	2.6	8.2	12.4	54.1	11.0	119.6	8.3	6.3	5.5	8.2	14.6	15.6	29.8	11.1	7.4	49.5	29.6	0.0	5.1	14.4	18.0	21.6	6.8	7.5	4.8	0.0	3.5	21.5	4.1	50.6	35.0	4.1	8.3	31.3	13.1	23.1	9.8	13.4	19.8	16.7	4.8	201.7	6.7	3.3	8.1	12.1	10.2	10.7	16.3	7.3	10.3	29.1	91.4	8.3	1.6	7.2	28.9	3.4	54.1	4.2	0.3	5.1	24.0	12.7	12.0	2.3	12.2	9.1	1.7	0.1	10.6	5.4	9.8	0.0	1.0	0.2	0.0	0.4	0.0	0.1	0.2	0.2	2.4	0.0	0.0	0.0	3.6	0.3	0.1	1.1	0.0	16.0	50.9	61.3	54.5	60.9	46.3	51.7	56.6	54.4	53.7	53.0	55.5	54.1	4.4	0.0	0.5	38.5	3.8	12.6	12.0	14.4	6.8	0.5	6.9	4.6	1.7	12.8	6.3	11.0	0.0	0.4	0.2	1.4	0.0	48.4	4.0	9.2	15.8	11.2	6.0	89.7	1.6	30.5	0.8	11.3	6.6	18.7	5.7	10.4	13.6	2.3	20.6	0.0	3.5	3.0	6.1	3.1	10.2	7.7	14.6	73.3	8.8	5.6	22.6	25.4	1.0	9.0	6.2	131.3	1.5	13.5	7.4	13.1	4.0	3.8	1.2	1.4	0.0	2.7	10.2	19.1	7.8	2.1	10.5	0.3	2.1	1.9	3.7	12.6
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin like modifier 1"	P63165	2	202206182-202238599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.6"	"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	77.5	99.1	79.4	62.7	84.9	133.7	83.6	89.0	99.9	68.9	84.4	82.7	72.0	65.1	86.3	71.6	65.7	71.7	79.8	85.6	85.3	118.1	174.1	66.5	86.4	79.9	80.1	54.5	55.8	91.6	56.7	75.6	81.1	75.3	82.8	80.2	66.8	61.9	107.5	57.1	80.5	71.5	78.9	68.1	73.8	54.7	81.4	112.1	102.3	103.3	95.4	77.9	54.9	86.6	164.1	82.4	291.4	155.8	159.3	168.5	129.7	171.0	214.6	209.0	274.6	178.1	203.7	111.6	153.5	199.0	193.5	117.1	242.2	237.9	325.0	104.8	185.7	207.6	159.0	211.2	114.9	237.2	188.5	130.9	225.2	164.0	123.9	195.1	197.3	219.0	194.2	176.0	226.4	141.1	298.3	391.6	351.7	168.5	172.2	190.9	163.2	197.9	255.5	134.3	201.7	219.3	140.3	133.6	236.4	313.9	120.0	223.2	139.9	152.5	153.0	141.4	152.8	151.7	322.9	285.8	170.2	165.4	137.2	242.2	220.0	284.2	169.2	226.5	179.6	276.3	206.8	200.0	223.6	231.6	193.8	202.3	256.5	246.5	239.7	187.8	329.0	394.7	79.4	84.9	89.0	99.9	85.6	85.3	79.9	80.1	81.1	78.9	81.4	86.6	182.7	112.2	61.1	10.7	143.1	422.1	204.4	448.6	177.6	99.6	196.8	170.2	58.1	130.1	215.3	189.4	64.6	259.4	162.3	136.6	481.3	250.4	91.3	148.3	115.1	170.7	142.4	140.1	31.4	173.3	297.8	161.8	89.7	115.2	92.6	114.7	142.8	202.1	205.3	87.5	27.8	156.4	319.4	140.7	330.2	28.0	129.8	137.7	211.7	15.9	241.3	182.3	176.1	16.6	21.2	208.1	191.1	127.9	130.5	258.5	272.2	534.4	185.5	87.8	111.7	92.5	221.9	212.0	141.5	183.9	424.5	209.7	174.5	134.9	157.5	254.1
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 343.8;Late spermatids: 576.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	72.4	26.9	26.1	17.9	25.4	8.3	60.7	43.4	30.7	75.3	29.1	52.3	33.8	73.3	38.5	43.8	66.1	28.2	77.4	25.2	24.3	44.3	28.2	41.7	23.6	23.5	27.2	84.1	34.1	53.0	59.0	47.3	23.1	39.2	30.2	41.4	44.7	34.0	119.2	87.1	42.1	41.5	23.8	38.8	48.1	45.5	24.3	20.0	44.3	99.1	25.1	38.9	57.4	25.3	128.7	34.2	40.2	65.5	43.4	61.6	39.2	31.7	53.4	58.0	59.0	29.1	139.8	30.5	32.2	43.7	113.5	156.8	33.3	55.9	55.9	13.2	33.3	10.0	51.0	27.8	55.3	15.2	24.3	31.0	65.6	46.3	76.4	53.7	42.7	19.0	41.9	22.4	58.6	44.5	10.1	25.2	56.0	44.3	39.0	21.9	22.3	28.7	59.1	40.7	77.2	49.9	40.1	81.4	31.5	64.6	64.6	15.4	32.5	52.8	47.6	55.1	53.2	20.4	25.6	19.0	36.6	12.7	74.4	11.6	9.4	2.5	4.0	8.3	4.2	6.8	7.9	4.6	7.5	5.5	11.0	7.2	0.5	6.6	6.4	1.5	7.3	6.4	26.1	25.4	43.4	30.7	25.2	24.3	23.5	27.2	23.1	23.8	24.3	25.3	107.0	44.8	36.4	63.0	26.5	106.7	96.9	73.2	50.7	72.4	48.0	38.1	103.7	31.5	68.5	40.5	87.6	37.4	14.1	61.9	27.4	41.5	343.8	168.5	40.3	79.9	40.7	31.5	76.5	23.2	23.5	52.6	60.1	143.7	17.1	73.4	62.4	39.1	17.9	112.7	64.5	45.1	59.0	20.0	34.3	576.2	57.2	16.8	42.7	43.1	16.6	24.0	10.3	48.7	49.8	55.8	68.4	42.5	26.4	84.6	37.7	21.9	163.5	67.6	65.7	53.5	73.4	40.9	49.4	36.1	85.7	38.4	22.0	26.1	38.2	137.4
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	137.8	35.1	123.6	73.6	219.0	160.4	111.7	149.1	155.3	95.4	41.4	107.8	47.6	128.2	22.2	84.0	125.3	41.1	86.7	118.3	133.1	52.8	121.9	107.0	104.0	187.1	182.2	112.9	78.0	18.2	40.3	28.7	170.7	78.2	25.2	12.3	74.9	52.1	145.4	90.3	93.1	46.1	107.2	97.2	94.3	34.6	163.3	74.3	53.1	63.8	60.0	121.7	89.0	257.7	89.8	41.0	40.0	44.7	118.8	29.5	52.0	60.2	69.4	69.7	58.9	36.8	98.7	28.1	71.9	85.9	43.1	65.4	13.4	44.7	28.4	98.0	54.7	18.4	44.7	33.7	71.9	62.3	184.0	25.0	37.3	33.6	31.2	46.9	56.2	55.3	23.5	154.3	38.5	28.7	35.0	53.9	3.9	63.0	26.2	57.6	55.8	85.7	17.4	43.1	35.3	13.2	67.0	73.7	35.1	18.5	49.5	115.3	95.2	50.6	43.3	44.9	79.5	113.1	38.2	30.4	93.8	74.2	86.6	29.0	13.7	18.6	42.3	15.6	27.5	10.8	27.0	34.9	10.7	10.1	27.6	33.6	13.9	24.8	26.9	6.7	19.9	24.8	123.6	219.0	149.1	155.3	118.3	133.1	187.1	182.2	170.7	107.2	163.3	257.7	55.5	22.4	22.9	20.2	57.0	18.1	28.4	15.1	24.5	9.9	36.5	39.0	6.2	40.0	17.8	33.1	8.4	16.9	141.8	65.6	3.9	34.9	1.8	11.6	15.8	37.4	18.6	31.8	12.5	47.6	65.9	34.0	42.8	32.9	25.4	41.5	52.1	109.6	25.0	21.9	7.7	30.1	8.2	42.4	21.4	4.4	61.2	41.8	17.8	16.9	25.5	21.4	201.8	7.1	132.9	60.0	41.8	65.5	44.7	22.0	42.2	18.9	5.7	13.0	52.6	100.7	37.0	3.8	1.1	32.1	17.2	14.8	133.4	10.9	21.4	21.4
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.5;choroid plexus: 182.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 56.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 29.8;U-266/70: 29.1"	"Low region specificity"	"Detected in all"							HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		72000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	15.4	17.8	60.2	7.5	68.8	53.6	14.4	152.5	70.2	18.9	182.9	17.2	2.3	19.1	23.7	5.6	26.4	7.9	32.3	92.4	58.1	34.7	14.6	31.3	17.1	55.0	58.8	44.5	20.6	23.6	56.8	4.4	55.6	17.0	6.2	66.3	5.0	12.6	28.0	19.6	11.4	13.1	38.3	32.9	21.6	17.6	55.4	23.9	44.7	16.5	13.4	16.3	12.9	51.5	0.2	5.8	3.7	4.4	5.7	12.1	1.5	14.7	6.9	3.4	6.0	1.3	0.2	13.5	0.7	7.5	11.2	0.3	1.6	3.8	3.5	11.6	4.0	5.2	4.1	4.0	12.8	1.1	2.7	7.9	0.8	7.5	14.9	9.2	6.8	6.9	0.0	14.2	9.2	0.7	2.4	0.2	0.9	1.3	2.2	2.9	8.1	3.5	15.7	0.2	2.6	3.9	2.7	0.8	9.8	3.7	0.8	0.5	9.0	16.3	29.8	5.9	7.6	29.1	12.5	23.3	8.8	2.9	4.6	10.2	2.3	56.8	11.8	1.8	7.9	6.9	10.3	13.4	1.8	8.2	9.7	10.9	1.6	9.9	3.9	1.5	13.2	3.5	60.2	68.8	152.5	70.2	92.4	58.1	55.0	58.8	55.6	38.3	55.4	51.5	139.7	166.7	215.2	550.1	29.1	12.7	5.4	3.0	3.4	332.1	4.9	9.7	117.2	7.2	53.1	44.1	200.1	0.9	132.9	0.4	3.9	24.0	11.5	132.0	118.2	127.5	3.0	11.6	494.6	7.7	14.2	79.6	7.7	17.8	15.2	13.1	90.0	21.8	8.0	138.0	482.6	11.5	2.0	10.1	15.0	12.6	33.2	16.0	16.0	315.7	12.8	27.3	210.1	256.4	108.6	4.2	0.1	39.9	79.6	5.1	0.0	17.8	146.7	145.5	26.3	145.8	85.6	3.9	5.7	2.2	9.7	1.2	74.7	62.2	0.4	2.2
SYNE3	"C14orf139, C14orf49, FLJ25605, LINC00341, NCRNA00341, Nesp3, Nesprin-3, NET53"	ENSG00000176438	"Spectrin repeat containing nuclear envelope family member 3"	Q6ZMZ3	14	95407266-95475836	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 19.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 70.2;Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 103.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 36.2;Karpas-707: 42.3;REH: 34.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA055227, HPA077140"	Approved		Supported	"Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear membrane"		"HPA055227: AB_2682747, HPA077140: AB_2686826"	"unprognostic (4.63e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.41e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.19e-2)"	19.1	3.4	5.1	4.3	9.5	13.7	12.6	5.8	6.7	4.0	8.7	2.8	1.5	2.3	1.4	2.0	4.5	2.1	4.3	4.5	5.5	1.1	3.0	4.4	6.0	10.0	8.0	4.0	0.9	0.4	1.7	3.4	7.4	1.6	2.6	11.9	3.2	1.1	2.2	4.3	3.8	2.2	5.6	5.0	2.1	2.7	8.3	2.4	2.9	3.3	6.0	3.2	4.1	12.3	1.2	0.1	0.7	1.1	46.5	36.2	14.3	5.4	9.4	5.1	4.0	7.8	1.3	6.3	0.9	2.6	1.6	0.3	1.1	4.0	2.3	20.9	0.9	4.3	0.9	2.1	6.0	6.6	10.4	10.2	1.4	6.4	3.7	0.4	9.0	1.9	0.3	42.3	3.9	1.5	3.9	7.3	0.1	0.2	2.6	34.8	23.2	13.5	0.6	0.7	1.0	5.1	0.2	0.1	2.5	0.6	2.0	9.6	8.2	3.7	2.2	5.0	0.7	5.0	11.1	5.9	7.4	14.6	28.2	2.2	1.9	0.1	0.7	1.5	0.9	1.2	1.0	0.8	0.8	1.0	1.2	1.0	0.9	0.3	1.6	1.0	0.9	1.0	5.1	9.5	5.8	6.7	4.5	5.5	10.0	8.0	7.4	5.6	8.3	12.3	12.4	9.6	18.3	3.3	19.7	2.3	0.4	0.1	0.6	5.1	1.0	1.3	70.2	0.0	0.7	0.0	62.6	2.2	16.1	4.9	0.0	0.0	3.9	6.5	5.1	14.7	1.2	4.0	2.5	0.4	15.0	22.3	1.1	1.4	12.0	0.2	5.0	6.8	4.3	6.7	3.3	5.0	0.0	17.6	14.8	2.4	13.1	20.3	5.4	3.7	27.8	5.3	9.2	14.1	20.8	0.5	6.2	0.4	20.6	1.9	2.9	0.4	6.6	103.7	6.6	19.1	12.1	0.6	1.1	0.3	1.0	1.9	14.0	0.0	1.9	0.5
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216662-133218354	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 4.2"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 23.5;Spermatogonia: 31.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077304			Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA077304: "	"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.5	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM201	"Ima1, NET5, RP13-15M17.2, SAMP1"	ENSG00000188807	"Transmembrane protein 201"	Q5SNT2	1	9588911-9614877	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB039039	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear membrane"	Nucleoplasm	"CAB039039: "	"unprognostic (1.75e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.88e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (2.22e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.45e-1)"	5.8	6.1	8.6	3.6	8.9	7.7	5.2	7.9	9.7	7.5	6.8	5.7	3.2	7.3	2.0	7.0	6.3	2.2	14.5	9.4	8.4	9.5	3.4	4.0	3.2	10.8	9.7	9.4	6.1	4.4	16.0	2.5	9.5	6.4	1.3	6.1	5.5	2.9	43.2	6.4	4.7	2.7	7.9	5.4	4.6	10.4	9.6	3.2	5.5	24.3	2.0	5.2	5.5	8.3	13.6	18.2	11.1	26.3	4.6	3.1	9.9	15.7	4.8	18.3	12.9	33.1	12.0	23.5	19.4	5.5	9.0	27.9	12.4	12.4	6.2	15.7	31.2	16.7	17.4	17.0	8.4	20.4	16.6	5.7	5.5	24.6	3.9	3.9	7.3	10.9	21.7	6.6	7.5	16.0	17.8	14.8	11.2	10.3	16.4	37.1	19.0	19.3	6.6	7.3	26.6	19.9	12.3	29.9	13.5	3.8	9.1	12.7	6.7	21.7	18.8	24.0	30.0	11.0	9.9	21.0	15.0	33.0	19.6	0.0	0.2	0.0	0.3	0.2	0.1	0.5	0.3	0.5	0.3	0.2	0.2	0.2	0.0	0.1	0.1	1.3	0.5	0.3	8.6	8.9	7.9	9.7	9.4	8.4	10.8	9.7	9.5	7.9	9.6	8.3	5.2	3.2	2.0	4.9	2.2	7.0	2.5	1.8	4.6	16.0	5.3	4.7	12.1	2.8	2.1	0.0	27.1	4.1	0.8	2.6	1.9	2.3	2.0	4.2	4.9	4.9	6.7	5.2	4.1	1.0	2.5	4.0	2.6	4.4	4.5	11.7	3.6	1.6	3.6	10.1	6.0	3.7	2.0	2.5	3.5	1.8	4.1	2.4	3.6	0.0	0.9	5.0	1.0	7.1	5.9	1.7	0.9	4.5	2.8	3.2	0.6	1.9	2.4	16.9	0.0	7.3	4.2	6.8	5.4	7.9	5.5	0.8	2.8	4.6	4.3	2.3
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515579-98550351	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 139.9"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	17.1	13.9	8.4	44.0	9.4	93.2	24.3	19.1	15.1	23.2	10.1	34.5	34.1	30.8	34.4	27.0	22.8	17.7	11.0	9.1	9.6	21.7	37.2	21.9	78.7	9.7	8.9	56.2	25.3	17.8	8.4	29.4	9.6	17.2	36.4	20.7	16.5	19.1	12.2	22.7	39.6	22.3	8.8	39.1	35.7	23.1	9.6	139.9	15.2	12.2	78.1	20.7	20.7	14.2	180.5	117.5	283.3	145.5	23.1	30.7	166.2	145.0	77.1	193.9	139.5	129.5	88.9	314.4	86.2	85.6	70.7	113.0	240.8	110.1	177.1	217.7	148.5	269.1	103.3	86.5	21.2	315.4	170.8	17.6	35.4	115.0	61.2	66.9	112.8	192.0	231.8	118.1	122.0	114.7	514.9	248.6	170.1	167.2	108.6	421.3	187.2	218.6	69.3	167.7	221.9	132.2	248.9	155.2	79.3	110.6	174.3	149.2	60.4	111.1	96.5	76.8	150.8	125.9	231.9	344.0	32.0	179.5	151.0	48.6	30.4	13.4	18.9	54.1	20.5	22.4	21.9	21.6	23.4	27.2	30.0	23.5	2.4	20.7	75.9	12.9	28.5	30.5	8.4	9.4	19.1	15.1	9.1	9.6	9.7	8.9	9.6	8.8	9.6	14.2	45.4	32.1	27.9	3.6	70.1	27.8	23.7	18.7	28.5	21.1	21.2	28.6	9.0	25.8	33.5	31.3	12.5	36.0	48.5	63.0	31.3	19.5	42.7	29.5	29.8	38.0	28.7	172.1	20.3	31.5	89.7	32.2	56.1	42.7	29.1	70.1	34.2	50.0	38.2	10.1	15.3	63.4	16.2	63.1	34.9	32.1	28.6	73.4	17.8	23.4	63.5	20.3	54.6	14.6	19.1	26.7	28.5	40.6	81.9	21.1	33.7	33.1	25.6	52.6	19.7	27.3	32.0	54.0	59.4	62.8	23.3	11.8	60.8	32.4	62.4	21.8
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	30.4	18.3	10.8	29.0	8.9	51.8	30.1	16.2	14.2	40.8	2.2	56.3	25.3	57.6	16.4	26.0	43.5	22.4	22.1	10.3	0.5	22.9	19.8	32.0	16.1	6.2	1.7	46.0	29.5	35.0	22.2	30.6	1.6	36.1	22.6	12.2	28.8	34.3	24.0	33.2	29.0	36.4	1.3	25.2	33.8	22.6	5.1	17.2	32.6	11.1	14.6	40.8	31.9	3.2	72.8	63.4	51.5	43.4	42.9	50.6	133.8	50.4	47.3	27.4	29.0	26.3	62.4	49.3	48.3	74.7	60.8	79.7	30.2	60.5	23.0	21.6	19.2	31.4	56.6	43.1	37.1	104.3	111.2	51.2	70.0	54.8	63.2	39.5	31.3	43.6	45.4	27.2	35.3	120.0	24.6	127.2	4.5	47.5	48.0	27.0	25.7	37.3	22.3	91.3	22.3	53.4	38.8	102.5	37.0	23.1	106.9	106.1	78.7	78.3	109.6	47.0	36.7	38.6	44.1	46.2	44.1	72.6	94.1	14.2	3.8	3.6	1.7	1.5	1.2	2.2	1.2	1.0	1.4	2.3	0.9	1.7	20.8	3.2	2.1	5.4	1.9	0.2	10.8	8.9	16.2	14.2	10.3	0.5	6.2	1.7	1.6	1.3	5.1	3.2	25.6	9.6	29.0	59.7	7.4	9.3	3.7	9.8	13.6	51.7	15.8	25.9	7.5	14.3	12.4	14.7	2.1	14.5	20.4	33.6	1.9	5.0	14.4	22.2	29.7	17.3	31.3	9.7	40.9	6.6	3.8	17.8	19.4	36.2	14.0	48.3	29.6	25.4	11.2	50.5	45.6	30.4	8.2	41.8	12.4	18.8	18.3	22.8	5.4	71.2	25.9	31.0	11.3	32.6	20.3	9.0	10.6	19.9	12.1	6.5	7.4	5.4	11.1	4.0	19.7	18.4	21.2	0.4	2.1	12.5	8.8	10.0	12.3	18.6	25.1	3.8
TOR1A	"DQ2, DYT1"	ENSG00000136827	"Torsin family 1 member A"	O14656	9	129812942-129824244	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012473, HPA051195"	Approved		Supported	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA		20000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane, Vesicles"		"CAB012473: AB_2240792, HPA051195: AB_2681382"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-1)"	21.2	24.2	14.3	20.7	14.8	34.5	19.6	14.7	17.7	18.6	14.2	20.7	16.6	20.3	19.9	14.3	17.2	20.6	16.8	15.7	15.9	20.5	35.9	19.4	22.9	13.6	14.0	17.2	19.5	19.4	14.3	23.5	14.0	21.3	22.3	9.8	17.0	23.1	16.4	17.8	18.8	25.4	14.1	18.8	18.1	9.2	15.4	26.3	23.8	14.9	19.0	28.6	15.6	14.8	33.7	49.5	35.9	41.5	53.1	51.3	47.4	76.7	94.5	67.0	57.2	32.3	48.2	41.0	44.0	99.7	46.0	77.2	34.7	50.8	54.7	65.7	32.9	36.9	49.8	32.3	66.9	82.1	65.5	69.8	50.7	63.5	45.6	61.5	73.2	65.3	66.5	32.3	74.6	84.3	58.9	79.3	53.8	39.2	55.6	30.5	56.5	41.9	54.9	42.4	27.0	47.6	79.3	30.7	43.3	40.1	61.6	63.4	65.1	66.1	37.7	49.6	59.6	36.6	87.0	37.7	49.0	46.9	54.3	95.5	72.8	141.3	57.4	68.5	48.1	45.5	48.4	52.1	61.4	33.5	40.9	42.4	72.7	68.6	58.3	56.5	59.1	78.9	14.3	14.8	14.7	17.7	15.7	15.9	13.6	14.0	14.0	14.1	15.4	14.8	25.0	9.6	11.8	5.5	17.5	17.6	16.6	39.5	12.0	11.2	16.5	15.9	9.9	18.6	24.4	14.7	2.1	47.9	39.3	18.7	15.6	42.1	0.7	12.5	18.8	24.2	19.2	30.5	6.3	49.9	65.7	25.0	13.7	15.0	22.2	23.4	16.1	22.7	45.2	21.9	6.4	17.8	26.4	19.1	22.4	1.3	12.8	27.9	14.2	3.7	47.6	18.5	35.0	9.5	6.6	40.1	18.9	15.4	23.7	24.7	21.0	17.0	14.9	9.2	32.9	15.2	24.3	7.3	10.1	9.3	18.5	53.4	25.5	23.4	15.4	19.6
TOR1AIP1	"FLJ13142, LAP1, LAP1B, LAP1C"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179920077	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 275.9;Late spermatids: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	39.7	34.8	20.4	27.2	23.6	84.5	33.9	22.4	25.0	42.6	29.0	46.5	15.9	40.5	35.9	40.6	31.6	34.3	38.5	18.1	21.4	36.5	38.4	35.5	34.2	23.6	23.3	54.5	27.9	36.9	20.1	28.5	22.0	43.8	22.8	25.1	31.5	43.2	54.1	20.1	23.6	41.0	21.2	35.0	31.3	27.0	21.5	27.5	46.8	74.8	27.6	40.4	26.4	24.5	37.1	36.4	24.9	32.3	109.7	73.6	47.7	48.2	57.7	44.5	45.6	28.5	68.5	9.7	52.1	50.2	31.8	63.5	23.6	39.6	52.8	62.9	23.2	26.4	31.5	28.5	50.4	90.8	78.4	57.8	29.8	55.3	51.3	50.1	40.9	39.5	39.2	47.6	47.9	33.1	37.4	28.5	35.5	47.9	13.9	22.8	38.9	25.5	43.7	71.3	20.9	29.2	60.7	57.9	83.6	36.6	44.3	91.9	41.9	60.7	26.5	42.0	58.8	53.4	75.3	19.5	23.6	49.3	95.1	177.7	86.0	205.3	76.4	94.8	89.6	54.9	68.9	76.8	90.8	66.7	71.0	73.1	132.8	74.6	127.5	65.1	81.9	115.5	20.4	23.6	22.4	25.0	18.1	21.4	23.6	23.3	22.0	21.2	21.5	24.5	42.4	32.1	36.1	21.2	33.9	43.3	64.4	21.3	48.3	11.8	27.5	17.8	30.2	18.6	24.2	20.2	16.7	16.2	44.1	13.1	13.7	20.5	275.9	25.9	30.9	33.6	20.3	25.2	13.6	25.2	26.0	51.7	23.4	48.4	36.1	19.8	36.8	27.4	27.6	6.7	16.9	10.6	20.3	48.5	26.1	190.0	47.5	40.4	14.2	21.5	36.6	40.5	35.0	15.6	26.9	29.0	12.5	58.6	32.8	48.4	11.1	19.2	29.2	13.6	26.3	72.5	38.0	14.0	20.4	38.1	37.5	18.2	47.5	23.6	8.3	54.0
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018287-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	8.4	12.4	11.2	7.3	11.3	4.7	8.4	10.9	11.4	9.1	11.9	9.5	5.4	9.3	8.6	7.4	8.3	5.7	16.5	11.1	12.1	11.8	14.1	6.3	10.6	11.4	11.5	9.3	7.5	11.6	7.5	8.4	11.4	8.3	7.2	5.8	7.1	7.0	32.7	6.3	7.6	11.5	11.4	12.5	8.7	15.6	12.1	10.4	7.4	29.1	10.6	9.1	7.6	11.8	15.2	24.8	30.3	35.1	17.2	15.5	20.6	19.5	23.5	36.5	36.3	29.7	25.5	34.2	13.7	24.4	48.5	13.4	40.1	29.2	35.0	22.7	34.2	24.1	21.4	29.1	27.7	27.4	22.9	18.4	21.2	38.1	24.2	20.1	39.5	28.9	73.7	11.7	35.5	26.5	33.2	51.9	62.5	26.0	28.0	31.0	23.6	29.5	37.0	10.7	19.3	34.3	27.5	39.4	30.7	42.9	17.3	28.6	17.6	24.2	11.5	20.5	32.8	22.9	36.8	44.7	37.8	34.9	41.2	34.5	24.6	23.8	26.0	29.4	29.5	39.3	26.6	27.5	31.2	37.1	35.2	27.7	2.0	29.5	28.3	18.6	30.8	24.6	11.2	11.3	10.9	11.4	11.1	12.1	11.4	11.5	11.4	11.4	12.1	11.8	5.2	6.4	2.3	12.4	8.8	1.5	5.4	16.0	11.4	6.1	4.3	5.8	13.5	4.3	7.5	7.3	0.0	19.2	4.8	2.3	17.6	12.8	3.3	3.1	5.5	8.6	3.6	5.2	13.8	9.7	16.9	8.1	4.1	2.6	4.5	12.4	11.4	9.1	9.0	6.7	15.7	4.2	16.2	5.0	3.0	5.2	8.7	4.3	1.8	9.4	11.6	6.9	9.2	11.6	12.4	8.9	7.7	6.4	9.1	2.3	2.6	22.1	8.9	5.9	0.0	7.4	8.3	42.0	22.9	5.0	1.7	7.4	7.0	9.4	4.9	2.2
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 51: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear membrane"	Nucleoplasm	"HPA054045: AB_2682354"	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.53e-7)"	15.5	15.4	12.5	17.6	14.2	9.6	17.0	15.9	13.9	16.2	16.0	15.0	18.1	17.8	23.1	9.4	16.1	13.8	12.5	12.3	13.3	14.3	15.8	16.3	22.4	13.1	13.2	20.6	14.7	14.1	19.5	14.8	13.7	17.1	21.2	17.8	15.6	15.7	7.5	24.6	22.2	13.3	12.6	27.2	16.0	6.4	13.4	18.3	19.8	5.9	22.6	12.7	13.0	16.7	8.5	13.9	14.7	12.1	14.4	15.0	12.0	10.5	15.6	7.1	16.2	7.0	6.6	10.2	11.3	13.9	5.4	9.5	8.1	9.0	9.4	10.5	16.4	19.7	26.5	7.3	7.6	14.3	22.0	18.6	16.0	8.8	13.1	22.6	13.1	10.1	6.1	12.0	12.0	2.2	12.6	17.2	6.4	4.7	9.5	7.4	15.9	6.3	10.8	26.9	7.5	17.1	14.4	6.2	5.0	14.4	6.1	18.5	13.8	15.7	10.1	7.1	7.4	16.2	16.3	5.8	8.4	11.0	7.4	49.6	9.1	22.0	18.4	6.3	20.3	16.9	15.5	18.7	9.7	17.8	19.5	15.1	6.9	16.7	13.7	8.7	19.5	10.4	12.5	14.2	15.9	13.9	12.3	13.3	13.1	13.2	13.7	12.6	13.4	16.7	16.0	22.4	14.6	16.3	26.2	5.6	7.3	14.7	10.8	26.8	9.1	5.7	4.7	18.6	11.3	25.8	18.8	13.1	30.4	14.5	1.9	8.1	14.5	7.9	9.9	12.2	9.6	12.0	26.2	5.3	8.1	12.4	8.6	8.2	21.0	20.5	16.1	7.6	7.3	26.9	23.4	11.2	20.3	13.9	8.9	4.4	16.1	10.4	5.4	14.0	19.8	11.8	47.4	14.1	29.0	8.6	13.3	13.9	12.1	10.4	29.8	3.3	7.4	22.1	13.1	10.9	9.3	5.4	4.1	6.8	6.8	8.2	27.3	19.9	11.0	9.3
ZNF383	"FLJ35863, Zfp383"	ENSG00000188283	"Zinc finger protein 383"	Q8NA42	19	37217926-37248738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063945	Approved		Supported	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA063945: AB_2685158"	"unprognostic (1.92e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.27e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-3)"	"prognostic favorable (3.71e-4)"	3.6	3.2	2.5	3.4	4.4	3.5	5.1	8.5	3.4	4.1	1.5	3.3	3.5	3.8	3.6	3.6	3.7	2.9	4.9	2.7	3.5	4.4	3.2	3.5	6.1	3.7	3.1	5.8	2.9	4.4	2.8	3.2	3.8	4.1	3.5	5.4	4.0	3.9	7.4	5.4	3.4	3.8	2.0	5.1	3.9	3.9	3.7	5.7	5.3	9.0	6.0	3.4	3.4	7.1	2.9	6.8	4.6	7.1	5.7	5.8	3.1	4.1	5.6	4.0	5.9	3.1	3.6	4.0	5.9	3.9	3.8	3.0	3.6	5.5	5.9	5.4	4.2	5.7	5.2	2.6	6.1	6.9	6.2	7.1	4.6	3.9	7.6	5.1	3.7	5.5	3.2	2.1	5.0	1.4	6.3	3.2	4.2	5.8	1.9	4.4	8.4	3.7	3.6	8.2	5.2	4.1	6.6	3.8	5.7	5.8	4.6	4.1	2.3	5.0	3.5	3.7	4.0	6.5	6.4	7.9	0.7	3.2	4.7	3.7	3.2	5.3	5.8	3.9	8.2	8.0	5.4	7.1	3.3	10.7	8.6	6.9	3.5	4.8	4.9	3.1	6.0	3.9	2.5	4.4	8.5	3.4	2.7	3.5	3.7	3.1	3.8	2.0	3.7	7.1	7.2	3.2	4.4	7.5	10.2	2.7	4.0	3.4	5.7	9.8	3.7	5.2	12.8	7.2	2.5	1.8	14.6	3.8	7.5	3.8	1.9	3.5	8.9	3.6	5.4	5.1	2.4	11.0	7.4	3.6	4.8	5.8	4.6	3.7	5.7	7.8	6.4	2.2	3.8	15.2	8.7	3.8	2.0	6.3	3.5	3.0	6.5	4.5	8.8	4.7	5.5	6.2	10.3	9.5	10.4	2.7	3.6	7.5	3.8	5.1	5.8	3.9	2.5	9.9	13.1	9.9	6.1	5.8	5.2	3.9	3.3	4.9	8.5	6.6	4.8	4.1
